KR101072812B1 - Chemiclal having an asymmetric structure which froms the ring by combining carbazole and fluorine and organic electroric element using the same, terminal thererof - Google Patents

Chemiclal having an asymmetric structure which froms the ring by combining carbazole and fluorine and organic electroric element using the same, terminal thererof Download PDF

Info

Publication number
KR101072812B1
KR101072812B1 KR1020090026838A KR20090026838A KR101072812B1 KR 101072812 B1 KR101072812 B1 KR 101072812B1 KR 1020090026838 A KR1020090026838 A KR 1020090026838A KR 20090026838 A KR20090026838 A KR 20090026838A KR 101072812 B1 KR101072812 B1 KR 101072812B1
Authority
KR
South Korea
Prior art keywords
group
phenanthroline
diary
compound
light emitting
Prior art date
Application number
KR1020090026838A
Other languages
Korean (ko)
Other versions
KR20100108701A (en
Inventor
김대성
최대혁
김동하
박정환
Original Assignee
덕산하이메탈(주)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 덕산하이메탈(주) filed Critical 덕산하이메탈(주)
Priority to KR1020090026838A priority Critical patent/KR101072812B1/en
Priority to CN201080015465.4A priority patent/CN102482279B/en
Priority to PCT/KR2010/001905 priority patent/WO2010114267A2/en
Priority to EP10758992.1A priority patent/EP2415773B1/en
Priority to JP2012501944A priority patent/JP5390693B2/en
Priority to US13/262,479 priority patent/US9233923B2/en
Publication of KR20100108701A publication Critical patent/KR20100108701A/en
Application granted granted Critical
Publication of KR101072812B1 publication Critical patent/KR101072812B1/en
Priority to JP2013187250A priority patent/JP5902655B2/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/14Carrier transporting layers
    • H10K50/15Hole transporting layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/17Carrier injection layers
    • H10K50/171Electron injection layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/631Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
    • H10K85/633Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine comprising polycyclic condensed aromatic hydrocarbons as substituents on the nitrogen atom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1014Carbocyclic compounds bridged by heteroatoms, e.g. N, P, Si or B
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Optics & Photonics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

본 발명은 카바졸과 플루오렌이 결합하여 고리를 형성하는 비대칭 구조를 갖는 화합물 및 이를 이용한 유기전자소자, 그 단말을 제공한다.The present invention provides a compound having an asymmetric structure in which carbazole and fluorene are bonded to form a ring, an organic electronic device using the same, and a terminal thereof.

유기전자소자, 카바졸, 플루오렌 Organic electronic devices, carbazole, fluorene

Description

카바졸과 플루오렌이 결합하여 고리를 형성하는 비대칭 구조를 갖는 화합물 및 이를 이용한 유기전자소자, 그 단말{CHEMICLAL HAVING AN ASYMMETRIC STRUCTURE WHICH FROMS THE RING BY COMBINING CARBAZOLE AND FLUORINE AND ORGANIC ELECTRORIC ELEMENT USING THE SAME, TERMINAL THEREROF}FIELD OF THE INVENTION A compound having an asymmetric structure in which carbazole and fluorene bond to form a ring, and an organic electronic device using the same, and a terminal thereof THEREROF}

본 발명은 카바졸과 플루오렌이 결합하여 고리를 형성하는 비대칭 구조를 갖는 화합물 및 이를 이용한 유기전자소자, 그 단말에 관한 것이다. The present invention relates to a compound having an asymmetric structure in which carbazole and fluorene are bonded to form a ring, an organic electronic device using the same, and a terminal thereof.

일반적으로 유기 발광 현상이란 유기 물질을 이용하여 전기에너지를 빛에너지로 전환시켜주는 현상을 말한다. 유기 발광 현상을 이용하는 유기전자소자는 통상 양극과 음극 및 이 사이에 유기물층을 포함하는 구조를 가진다. 여기서 유기물층은 유기전자소자의 효율과 안정성을 높이기 위하여 각기 다른 물질로 구성된 다층의 구조로 이루어진 경우가 많으며, 예컨대 정공주입층, 정공수송층, 발광층, 전자수송층, 전자 주입층 등으로 이루어질 수 있다. In general, organic light emission phenomenon refers to a phenomenon in which an organic material is used to convert electric energy into light energy. An organic electronic device using an organic light emitting phenomenon usually has a structure including an anode, a cathode, and an organic material layer therebetween. In this case, the organic material layer is often formed of a multi-layered structure composed of different materials to increase the efficiency and stability of the organic electronic device, for example, it may be made of a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, an electron injection layer.

유기전자소자에서 유기물층으로 사용되는 재료는 기능에 따라, 발광 재료와 전하 수송 재료, 예컨대 정공주입 재료, 정공수송 재료, 전자수송 재료, 전자주입 재료 등으로 분류될 수 있다. 그리고, 상기 발광 재료는 분자량에 따라 고분자형과 저분자형으로 분류될 수 있고, 발광 메커니즘에 따라 전자의 일중항 여기상태로부터 유래되는 형광 재료와 전자의 삼중항 여기상태로부터 유래되는 인광 재료로 분류될 수 있다. 또한, 발광 재료는 발광색에 따라 청색, 녹색, 적색 발광 재료와 보다 나은 천연색을 구현하기 위해 필요한 노란색 및 주황색 발광 재료로 구분될 수 있다. Materials used as the organic material layer in the organic electronic device may be classified into light emitting materials and charge transport materials such as hole injection materials, hole transport materials, electron transport materials, electron injection materials and the like depending on their functions. The light emitting material may be classified into a polymer type and a low molecular type according to molecular weight, and may be classified into a fluorescent material derived from a singlet excited state of electrons and a phosphorescent material derived from a triplet excited state of electrons according to a light emitting mechanism. Can be. In addition, the light emitting material may be classified into blue, green, and red light emitting materials and yellow and orange light emitting materials required to achieve a better natural color according to the light emitting color.

한편, 발광 재료로서 하나의 물질만 사용하는 경우 분자간 상호 작용에 의하여 최대 발광 파장이 장파장으로 이동하고 색순도가 떨어지거나 발광 감쇄 효과로 소자의 효율이 감소되는 문제가 발생하므로, 색순도의 증가와 에너지 전이를 통한 발광 효율을 증가시키기 위하여 발광 재료로서 호스트/도판트 계를 사용할 수 있다. 그 원리는 발광층을 형성하는 호스트 보다 에너지 대역 간극이 작은 도판트를 발광층에 소량 혼합하면, 발광층에서 발생한 엑시톤이 도판트로 수송되어 효율이 높은 빛을 내는 것이다. 이때 호스트의 파장이 도판트의 파장대로 이동하므로, 이용하는 도판트의 종류에 따라 원하는 파장의 빛을 얻을 수 있다. On the other hand, when only one material is used as a light emitting material, there arises a problem that the maximum light emission wavelength shifts to a long wavelength due to intermolecular interaction, the color purity decreases, or the efficiency of the device decreases due to the light emission attenuating effect. A host / dopant system may be used as the light emitting material in order to increase the light emitting efficiency through the light emitting layer. The principle is that when a small amount of dopant having an energy band gap smaller than that of a host forming the light emitting layer is mixed in the light emitting layer, excitons generated in the light emitting layer are transported to the dopant, thereby producing high-efficiency light. At this time, since the wavelength of the host is shifted to the wavelength band of the dopant, the desired wavelength light can be obtained depending on the type of the dopant used.

전술한 유기전자소자가 갖는 우수한 특징들을 충분히 발휘하기 위해서는 소자내 유기물층을 이루는 물질, 예컨대 정공주입 물질, 정공수송 물질, 발광 물질, 전자수송 물질, 전자주입 물질 등이 안정하고 효율적인 재료에 의하여 뒷받침되는 것이 선행되어야 하나, 아직까지 안정하고 효율적인 유기전자소자용 유기물층 재료의 개발이 충분히 이루어지지 않은 상태이며, 따라서 새로운 재료의 개발이 계속 요구되고 있다.In order to fully exhibit the excellent characteristics of the organic electronic device described above, a material forming the organic material layer in the device, such as a hole injection material, a hole transport material, a light emitting material, an electron transport material, an electron injection material, etc., is supported by a stable and efficient material. Although this should be preceded, the development of a stable and efficient organic material layer for an organic electronic device has not been sufficiently achieved, and therefore, the development of a new material is still required.

본 발명자들은 신규한 구조를 갖도록 카바졸과 플루오렌이 결합하여 고리를 형성하는 비대칭 구조의 유도체를 밝혀내었으며, 또한 이 화합물을 유기전자소자에 적용시 소자의 발광효율, 안정성 및 수명을 크게 향상시킬 수 있다는 사실을 밝혀내었다.The inventors have found a derivative having an asymmetric structure in which carbazole and fluorene are bonded to form a ring to have a novel structure, and when the compound is applied to an organic electronic device, the luminous efficiency, stability and lifetime of the device are greatly improved. It turns out that you can.

이에 본 발명은 신규한 카바졸과 플루오렌이 결합하여 고리를 형성하는 비대칭 구조를 갖는 화합물 및 이를 이용한 유기전자소자, 그 단말을 제공하는 것을 목적으로 한다.Accordingly, an object of the present invention is to provide a compound having an asymmetric structure in which a novel carbazole and fluorene are bonded to form a ring, an organic electronic device using the same, and a terminal thereof.

일측면에서, 본 발명은 아래 화학식의 화합물을 제공한다.In one aspect, the present invention provides a compound of the formula

Figure 112009018902968-pat00001
Figure 112009018902968-pat00001

이때, 본 발명의 일실시예에 따른 화합물은 A를 중심으로 반드시 비대칭 구조를 갖는다. 한편, A가 단일결합일 경우, 이 단일결합을 중심으로 비대칭 구조를 갖는다.At this time, the compound according to an embodiment of the present invention has an asymmetric structure necessarily around A. On the other hand, when A is a single bond, it has an asymmetrical structure around this single bond.

유기전자소자에 적용된 화합물은 합성된 화합물에 따라서 적색, 녹색, 청색, 흰색 등의 모든 칼라의 인광 소자에 적합한 정공주입 재료 및 정공수송 재료 중 하나 이상의 재료로 사용될 수 있다. 유기전자소자에 적용된 화합물은 다양한 칼라의 인광 도판트 및 호스트 물질로 사용될 수 있다.The compound applied to the organic electronic device may be used as one or more of a hole injection material and a hole transport material suitable for phosphorescent devices of all colors, such as red, green, blue, and white, depending on the synthesized compound. Compounds applied to organic electronic devices can be used as phosphorescent dopants and host materials of various colors.

본 발명의 카바졸과 플루오렌이 결합하여 고리를 형성하는 비대칭 구조를 갖는 화합물은 유기전자소자 및 단말에서 다양한 역할을 할 수 있으며, 유기전자소자 및 단말에 적용시 소자의 고효율, 저전압, 고휘도, 장수명을 기대할 수 있다.Compounds having an asymmetric structure in which carbazole and fluorene are bonded to form a ring of the present invention may play various roles in organic electronic devices and terminals, and when applied to organic electronic devices and terminals, high efficiency, low voltage, high brightness, Long life can be expected.

이하, 본 발명의 일부 실시예들을 예시적인 도면을 통해 상세하게 설명한다. 각 도면의 구성요소들에 참조부호를 부가함에 있어서, 동일한 구성요소들에 대해서는 비록 다른 도면상에 표시되더라도 가능한 한 동일한 부호를 가지도록 하고 있음에 유의해야 한다. 또한, 본 발명을 설명함에 있어, 관련된 공지 구성 또는 기능에 대한 구체적인 설명이 본 발명의 요지를 흐릴 수 있다고 판단되는 경우에는 그 상세한 설명은 생략한다.Hereinafter, some embodiments of the present invention will be described in detail through exemplary drawings. In adding reference numerals to the components of each drawing, it should be noted that the same reference numerals are assigned to the same components as much as possible even though they are shown in different drawings. In the following description of the present invention, a detailed description of known functions and configurations incorporated herein will be omitted when it may make the subject matter of the present invention rather unclear.

또한, 본 발명의 구성 요소를 설명하는 데 있어서, 제 1, 제 2, A, B, (a), (b) 등의 용어를 사용할 수 있다. 이러한 용어는 그 구성 요소를 다른 구성 요소와 구별하기 위한 것일 뿐, 그 용어에 의해 해당 구성 요소의 본질이나 차례 또는 순 서 등이 한정되지 않는다. 어떤 구성 요소가 다른 구성요소에 "연결", "결합" 또는 "접속"된다고 기재된 경우, 그 구성 요소는 그 다른 구성요소에 직접적으로 연결되거나 또는 접속될 수 있지만, 각 구성 요소 사이에 또 다른 구성 요소가 "연결", "결합" 또는 "접속"될 수도 있다고 이해되어야 할 것이다.In addition, in describing the component of this invention, terms, such as 1st, 2nd, A, B, (a), (b), can be used. These terms are only for distinguishing the components from other components, and the nature, order or order of the components are not limited by the terms. If a component is described as being "connected", "coupled" or "connected" to another component, that component may be directly connected to or connected to that other component, but there may be another configuration between each component. It is to be understood that the elements may be "connected", "coupled" or "connected".

본 발명은 아래 화학식 1의 화합물을 제공한다.The present invention provides a compound of Formula 1 below.

Figure 112009018902968-pat00002
Figure 112009018902968-pat00002

위 화학식에 있어서, In the above formula,

(1) A는 독립적으로 단일결합을 의미하거나 치환 또는 비치환된 C2 -50의 알케닐기, 치환 또는 비치환된 C6 -50의 아릴렌기, 치환 또는 비치환된 C4 -60의 아릴기, S, N, O, P 및 Si 중 적어도 하나 이상의 헤테로 원자를 포함하는 C2 -50의 치환 또는 비치환된 알케닐기, S, N, O, P 및 Si 중 적어도 하나 이상의 헤테로 원자를 포함하는 C2 -50의 치환 또는 비치환된 아릴렌기, S, N, O, P 및 Si를 적어도 하나 이상의 헤테로 원자를 포함하는 C4 -60의 치환 또는 비치환된 아릴기로 구성된 군으로부터 선택된 하나일 수 있다.(1) A means a single bond, independently of, or a substituted or unsubstituted C 2 -50 alkenyl group, a substituted or unsubstituted C 6 -50 aryl group, a substituted or unsubstituted C 4 -60 ring of the ring of the aryl group , S, N, O, substituted or unsubstituted alkenyl group of 2 -50 C containing at least one heteroatom of P and Si, S, N, O, containing at least one heteroatom of P and Si substitution of C 2 -50 or unsubstituted arylene group, S, N, O, P, and it can be one selected from the group consisting of an Si group substituted or unsubstituted aryl group of C 4 -60 containing at least one heteroatom have.

(2) R1, R2, R3는 각각 서로 독립적으로 수소원자, 할로겐 원자, 시아노기, 알콕시기, 알킬티올기, 아릴티올기, 치환 또는 비치환된 C1-50의 알킬기, 치환 또는 비치환된 C1-50의 알콕시기, 치환 또는 비치환된 C2-50의 알케닐기, 치환 또는 비치환된 C6-50의 아릴렌기, 치환 또는 비치환된 C4-60의 아릴기, 치환 또는 비치환된 C4-60의 아릴옥시기, S, N, O, P 및 Si 중 적어도 하나 이상의 헤테로 원자를 포함하는 치환 또는 비치환된 C1 -50의 알킬기, S, N, O, P 및 Si 중 적어도 하나 이상의 헤테로 원자를 포함하는 치환 또는 비치환된 C1 -50의 알콕시기, S, N, O, P 및 Si 중 적어도 하나 이상의 헤테로 원자를 포함하는 C2 -50의 치환 또는 비치환된 알케닐기, S, N, O, P 및 Si 중 적어도 하나 이상의 헤테로 원자를 포함하는 C2 -50의 치환 또는 비치환된 아릴렌기, S, N, O, P 및 Si 중 적어도 하나 이상의 헤테로 원자를 포함하는 치환 또는 비치환된 C4 -60의 아릴기, S, N, O, P 및 Si 중 적어도 하나 이상의 헤테로 원자를 포함하는 치환 또는 비치환된 C4 -60의 아릴옥시기, -N(Ar5)2 또는 -N(Ar5)(Ar6)로 표현되는 치환 또는 비치환된 아미노기로 구성된 군으로부터 선택된 하나일 수 있다.(2) R 1 , R 2 , and R 3 each independently represent a hydrogen atom, a halogen atom, a cyano group, an alkoxy group, an alkylthiol group, an arylthiol group, a substituted or unsubstituted C 1-50 alkyl group, a substituted or Unsubstituted C 1-50 alkoxy group, substituted or unsubstituted C 2-50 alkenyl group, substituted or unsubstituted C 6-50 arylene group, substituted or unsubstituted C 4-60 aryl group, substituted or unsubstituted C 4-60 aryloxy group, S, N, O, optionally substituted containing at least one heteroatom of P and Si or unsubstituted alkyl group of C 1 -50, S, N, O, alkoxy group substituted with at least contains one or more hetero atoms of P and Si or unsubstituted C 1 -50, S, N, O, optionally substituted C 2 -50 of including at least one or more hetero atoms of P and Si or unsubstituted alkenyl group, S, N, O, P, and Si of at least a substituted or unsubstituted C 2 -50 ring containing one or more heteroatoms arylene group, S, N, Substituted or unsubstituted C 4 -60 aryl group containing at least one hetero atom of O, P and Si Substituted or unsubstituted containing at least one hetero atom of S, N, O, P and Si It may be one selected from the group consisting of a substituted or unsubstituted amino group represented by C 4 -60 aryloxy group, -N (Ar 5 ) 2 or -N (Ar 5 ) (Ar 6 ).

(3) Ar1, Ar2, Ar3는 서로 동일 또는 상이하며, 각각 독립적으로 치환 또는 비치환된 C6-50의 아릴렌기, 치환 또는 비치환된 C4-60의 아릴기, 치환 또는 비치환된 C4-60의 아릴옥시기, S, N, O, P 및 Si 중 적어도 하나 이상의 헤테로 원자를 포함하는 C2 -50의 치환 또는 비치환된 아릴렌기, S, N, O, P 및 Si 중 적어도 하나 이상의 헤테로 원자를 포함하는 치환 또는 비치환된 C4 -60의 아릴기, S, N, O, P 및 Si 중 적어도 하나 이상의 헤테로 원자를 포함하는 치환 또는 비치환된 C4 -60의 아릴옥시기로 구성된 군으로부터 선택된 하나일 수 있고, Ar1, Ar2는 서로 결합하여 고리를 형성할 수 있다.(3) Ar 1 , Ar 2 , Ar 3 are the same as or different from each other, each independently represent a substituted or unsubstituted C 6-50 arylene group, a substituted or unsubstituted C 4-60 aryl group, a substituted or unsubstituted hwandoen aryloxy group C 4-60, S, N, O , P , and Si of at least a substituted or non-substituted C 2 -50 ring containing one or more heteroatoms arylene group, S, N, O, P and an aryl group, a substituted or unsubstituted C 4 -60 containing at least one heteroatom of Si, S, N, O, substituted or unsubstituted C including at least one or more hetero atoms of P and Si 4 -60 It may be one selected from the group consisting of an aryloxy group, Ar 1 , Ar 2 may be bonded to each other to form a ring.

(4) Ar4는 독립적으로 수소이거나 치환 또는 비치환된 C6 -50의 아릴렌기, 치환 또는 비치환된 C4 -60의 아릴기, 치환 또는 비치환된 C4 -60의 아릴옥시기, S, N, O, P 및 Si 중 적어도 하나 이상의 헤테로 원자를 포함하는 C2 -50의 치환 또는 비치환된 아릴렌기, S, N, O, P 및 Si 중 적어도 하나 이상의 헤테로 원자를 포함하는 치환 또는 비치환된 C4 -60의 아릴기, S, N, O, P 및 Si 중 적어도 하나 이상의 헤테로 원자를 포함하는 치환 또는 비치환된 C4-60의 아릴옥시기, -N(Ar5)2 또는 -N(Ar5)(Ar6)로 표현되는 치환 또는 비치환된 아미노기로 구성된 군으로부터 선택된 하나일 수 있다. (4) Ar 4 are independently hydrogen or a substituted or unsubstituted C 6 -50 aryl group, an aryloxy group of a substituted or unsubstituted C 4 -60 aryl group, a substituted or unsubstituted C 4 -60 ring of the ring, S, N, O, substituted for at least one of P and a substituted or unsubstituted of C 2 -50 ring containing at least one or more hetero atoms in the arylene group, Si, S, N, O, P, and Si include one or more heteroatoms or unsubstituted C 4 -60 aryl group, S, N, O, an aryloxy group of a C 4-60 substituted or unsubstituted including at least one or more hetero atoms of P and Si, -N (Ar 5) It may be one selected from the group consisting of a substituted or unsubstituted amino group represented by 2 or -N (Ar 5 ) (Ar 6 ).

(5) n은 0 내지 5의 정수이고, 상기 Ar5 및 Ar6은 상기 Ar1 내지 Ar3과 동일 또는 상이할 수 있다.(5) n is an integer of 0 to 5, Ar 5 and Ar 6 may be the same as or different from Ar 1 to Ar 3 .

(6)아울러, 상기 구조식을 가지는 화합물은 용액 공정(soluble process)에 사용될 수 있다. 이 용액 공정은 저온공정이 가능하기 때문에 플라스틱 기판에도 쉽게 박막을 형성할 수 있고, 진공 장비의 사용을 최소화함으로써 공정단가를 낮출 수 있고, 대면적 공정이 가능한 장점들이 있다.In addition, the compound having the above structural formula can be used in a soluble process. Since the solution process can be carried out at low temperature, the thin film can be easily formed on the plastic substrate, and the process cost can be reduced by minimizing the use of vacuum equipment, and the large area process is possible.

결과적으로, 실시예에 따른 화합물은 카바졸과 플루오렌이 결합하여 고리를 형성하고 있는 비대칭 구조를 갖는다.As a result, the compound according to the embodiment has an asymmetric structure in which carbazole and fluorene are bonded to form a ring.

한편, 실시예에서 사용된 용어 "아릴기"는 페닐기, 나프틸기, 안트릴기, 페난트릴기, 나프타센일기, 피렌일기 및 크라이센일기, 플루오레닐기 등을 들 수 있으며, 바람직한 아릴기로는 페닐기, 나프틸기, 안트릴기, 페난트릴기, 플루오레닐기 및 피렌일기 등일 수 있으나 이에 한정되지 않는다.On the other hand, the term "aryl group" used in the examples include phenyl group, naphthyl group, anthryl group, phenanthryl group, naphthasenyl group, pyrenyl group and chrysenyl group, fluorenyl group and the like, preferred aryl groups It may be a phenyl group, naphthyl group, anthryl group, phenanthryl group, fluorenyl group and pyrenyl group and the like, but is not limited thereto.

또한, 실시예에서 사용된 용어 "헤테로 원자를 포함하는 방향족 헤테로환기"는 피롤릴기, 피라진일기, 피리딘일기, 인돌릴기, 아이소인돌릴기, 퓨릴기, 벤조퓨란일기, 아이소벤조퓨란일기, 퀴놀릴기, 아이소퀴놀릴기, 퀴녹살린일기, 카바졸릴기, 페난트리진일기, 아크리딘일기, 페난트롤린일기, 페나진일기, 페노싸이아진일기, 페녹사진일기, 옥사졸릴기, 옥사다이아졸릴기, 퓨라잔일기, 싸이엔일기 등을 들 수 있다.  바람직한 방향족 헤테로환기는 피롤릴기, 2-피롤릴기, 3-피롤릴기, 피라진일기, 2-피리딘일기, 3-피리딘일기, 4-피리딘일기, 1-인돌릴기, 2-인돌릴기, 3-인돌릴기, 4-인돌릴기, 5-인돌릴기, 6-인돌릴기, 7-인돌릴기, 1-아이소인돌릴기, 2-아이소인돌릴기, 3-아이소인돌릴기, 4-아이소인돌릴기, 5-아이소인돌릴기, 6-아이소인돌릴기, 7-아이소인돌릴기, 2-퓨릴기, 3-퓨릴기, 2-벤조퓨란일기, 3-벤조퓨 란일기, 4-벤조퓨란일기, 5-벤조퓨란일기, 6-벤조퓨란일기, 7-벤조퓨란일기, 1-아이소벤조퓨란일기, 3-아이소벤조퓨란일기, 4-아이소벤조퓨란일기, 5-아이소벤조퓨란일기, 6-아이소벤조퓨란일기, 7-아이소벤조퓨란일기, 퀴놀릴기, 3-퀴놀릴기, 4-퀴놀릴기, 5-퀴놀릴기, 6-퀴놀릴기, 7-퀴놀릴기, 8-퀴놀릴기, 1-아이소퀴놀릴기, 3-아이소퀴놀릴기, 4-아이소퀴놀릴기, 5-아이소퀴놀릴기, 6-아이소퀴놀릴기, 7-아이소퀴놀릴기, 8-아이소퀴놀릴기, 2-퀴녹살린일기, 5-퀴녹살린일기, 6-퀴녹살린일기, 1-카바졸릴기, 2-카바졸릴기, 3-카바졸릴기, 4-카바졸릴기, 9-카바졸릴기, 1-페난트리진일기 2-페난트리진일기, 3-페난트리진일기, 4-페난트리진일기, 6-페난트리진일기, 7-페난트리진일기, 8-페난트리진일기, 9-페난트리진일기, 10-페난트리진일기, 1-아크리딘일기, 2-아크리딘일기, 3-아크리딘일기, 4-아크리딘일기, 9-아크리딘일기, 1,7-페난트롤린-2-일기, 1,7-페난트롤린-3-일기, 1,7-페난트롤린-4-일기, 1,7-페난트롤린-5-일기, 1,7-페난트롤린-6-일기, 1,7-페난트롤린-8-일기, 1,7-페난트롤린-9-일기, 1,7-페난트롤린-10-일기, 1,8-페난트롤린-2-일기, 1,8-페난트롤린-3-일기, 1,8-페난트롤린-4-일기, 1,8-페난트롤린-5-일기, 1,8-페난트롤린-6-일기, 1,8-페난트롤린-7-일기, 1,8-페난트롤린-9-일기, 1,8-페난트롤린-10-일기, 1,9-페난트롤린-2-일기,1,9-페난트롤린-3-일기, 1,9-페난트롤린-4-일기, 1,9-페난트롤린-5-일기, 1,9-페난트롤린-6-일기, 1,9-페난트롤린-7-일기, 1,9-페난트롤린-8-일기, 1,9-페난트롤린-10-일기, 1,10-페난트롤린-2-일기, 1,10-페난트롤린-3-일기, 1,10-페난트롤린-4-일기, 1,10-페난트롤린-5-일기, 2,9-페난트롤린-1-일기, 2,9-페난트롤린-3-일기, 2,9-페난트롤린-4-일기, 2,9-페난트롤린-5-일기, 2,9-페난 트롤린-6-일기, 2,9-페난트롤린-7-일기, 2,9-페난트롤린-8-일기, 2,9-페난트롤린-10-일기, 2,8-페난트롤린-1-일기, 2,8-페난트롤린-3-일기, 2,8-페난트롤린-4-일기, 2,8-페난트롤린-5-일기, 2,8-페난트롤린-6-일기, 2,8-페난트롤린-7-일기, 2,8-페난트롤린-9-일기, 2,8-페난트롤린-10-일기, 2,7-페난트롤린-1-일기, 2,7-페난트롤린-3-일기, 2,7-페난트롤린-4-일기, 2,7-페난트롤린-5-일기, 2,7-페난트롤린-6-일기, 2,7-페난트롤린-8-일기, 2,7-페난트롤린-9-일기, 2,7-페난트롤린-10-일기, 1-페나진일기, 2-페나진일기, 1-페노싸이아진일기, 2-페노싸이아진일기, 3-페노싸이아진일기, 4-페노싸이아진일기, 10-페노싸이아진일기, 1-페녹사진일기, 2-페녹사진일기, 3-페녹사진일기, 4-페녹사진일기, 10-페녹사진일기, 2-옥사졸릴기, 4-옥사졸릴기, 5-옥사졸릴기, 2-옥사다이아졸릴기, 5-옥사다이아졸릴기, 3-퓨라잔일기, 2-싸이엔일기, 3-싸이엔일기, 2-메틸피롤-1-일기, 2-메틸피롤-3-일기, 2-메틸피롤-4-일기, 2-메틸피롤-5-일기, 3-메틸피롤-1-일기, 3-메틸피롤-2-일기, 3-메틸피롤-4-일기, 3-메틸피롤-5-일기, 2-t-뷰틸피롤-4-일기, 3-(2-페닐프로필)피롤-1-일기, 2-메틸-1-인돌릴기, 4-메틸-1-인돌릴기, 2-메틸-3-인돌릴기, 4-메틸-3-인돌릴기, 2-t-뷰틸1-인돌릴기, 4-t-뷰틸1-인돌릴기, 2-t-뷰틸3-인돌릴기 및 4-t-뷰틸3-인돌릴기를 들 수 있으나 이에 한정되지 않는다.In addition, the term "aromatic heterocyclic group containing a hetero atom" used in the examples is pyrrolyl group, pyrazinyl group, pyridinyl group, indolyl group, isoindolyl group, furyl group, benzofuranyl group, isobenzofuranyl group, quinolyl Group, isoquinolyl group, quinoxalineyl group, carbazolyl group, phenanthrizine group, acridinyl group, phenanthrolineyl group, phenazine group, phenoxyazine group, phenoxazineyl group, oxazolyl group, oxadiazolyl The group, furazanyl group, cyenyl group etc. are mentioned. Preferred aromatic heterocyclic groups are pyrrolyl group, 2-pyrrolyl group, 3-pyrrolyl group, pyrazinyl group, 2-pyridinyl group, 3-pyridinyl group, 4-pyridinyl group, 1-indolyl group, 2-indolyl group, 3-indolyl group , 4-indolyl group, 5-indolyl group, 6-indolyl group, 7-indolyl group, 1-isoindoleyl group, 2-isoindoleyl group, 3-isoindoleyl group, 4-isoindoleyl group, 5 -Isoindoleyl group, 6-isoindoleyl group, 7-isoindoleyl group, 2-furyl group, 3-furyl group, 2-benzofuranyl group, 3-benzofuranyl group, 4-benzofuranyl group, 5 -Benzofuranyl group, 6-benzofuranyl group, 7-benzofuranyl group, 1-isobenzofuranyl group, 3-isobenzofuranyl group, 4-isobenzofuranyl group, 5-isobenzofuranyl group, 6-isobenzofuran Diary, 7-isobenzofuranyl, quinolyl, 3-quinolyl, 4-quinolyl, 5-quinolyl, 6-quinolyl, 7-quinolyl, 8-quinolyl, 1 Isoquinolyl group, 3-isoquinolyl group, 4-isoquinol group, 5-isoquinolyl group , 6-isoquinolyl group, 7-isoquinolyl group, 8-isoquinolyl group, 2-quinoxalinyl group, 5-quinoxalinyl group, 6-quinoxalinyl group, 1-carbazolyl group, 2-carbazolyl Group, 3-carbazolyl group, 4-carbazolyl group, 9-carbazolyl group, 1-phenantrizinyl group 2-phenanthrylzinyl group, 3-phenanthrylzinyl group, 4-í-nantrizinyl group, 6-phenanyl Trizine diary, 7-phenanthrizine diary, 8-phenanthrizine diary, 9-phenanthrizine diary, 10-phenanthrizine diary, 1-acridinyl group, 2-acridinyl group, 3-acryl Dinyl, 4-acridinyl, 9-acridinyl, 1,7-phenanthroline-2-yl, 1,7-phenanthroline-3-yl, 1,7-phenanthroline-4 -Diary, 1,7-phenanthroline-5-diary, 1,7-phenanthroline-6-diary, 1,7-phenanthroline-8-diary, 1,7-phenanthroline-9-diary , 1,7-phenanthroline-10- diary, 1,8-phenanthroline-2-yl, 1,8-phenanthroline-3-yl, 1,8-phenanthroline-4-yl, 1 , 8-phenanthroline-5-diary, 1,8-phenanthroline-6-diary, 1,8-phenanthroline-7-diary, 1,8- Phenanthroline-9-diary, 1,8-phenanthroline-10-diary, 1,9-phenanthroline-2-yl, 1,9-phenanthroline-3-yl, 1,9-phenanthrole Lin-4-yl, 1,9-phenanthroline-5-diary, 1,9-phenanthroline-6-diary, 1,9-phenanthroline-7-diary, 1,9-phenanthroline- 8-diary, 1,9-phenanthroline-10-diary, 1,10-phenanthroline-2-yl, 1,10-phenanthroline-3-yl, 1,10-phenanthroline-4- Diary, 1,10-phenanthroline-5-diary, 2,9-phenanthroline-1-yl, 2,9-phenanthroline-3-yl, 2,9-phenanthroline-4-yl, 2,9-phenanthroline-5-diary, 2,9-phenanthroline-6-diary, 2,9-phenanthroline-7-diary, 2,9-phenanthroline-8-diary, 2, 9-phenanthroline-10- diary, 2,8-phenanthroline-1-yl, 2,8-phenanthroline-3-yl, 2,8-phenanthroline-4-yl, 2,8- Phenanthroline-5-diary, 2,8-phenanthroline-6-diary, 2,8-phenanthroline-7-diary, 2,8-phenanthroline-9-diary, 2,8-phenanthrole Lin-10-di, 2,7-phenanthroline-1-yl, 2,7-phenanthroline-3-yl, 2,7-phenanthroline-4-yl, 2,7- Nantrolin-5-diary, 2,7-phenanthroline-6-diary, 2,7-phenanthroline-8-diary, 2,7-phenanthroline-9-diary, 2,7-phenanthrole Rin-10- diary, 1-phenazine diary, 2-phenazine diary, 1-phenothiazin diary, 2-phenothiazin diary, 3-phenothiazin diary, 4-phenothiazin diary, 10-phenosai Azinyl group, 1-phenoxazine group, 2-phenoxazine group, 3-phenoxazine group, 4-phenoxazine group, 10-phenoxazine group, 2-oxazolyl group, 4-oxazolyl group, 5-oxazolyl group , 2-oxadiazolyl group, 5-oxadiazolyl group, 3-furazanyl group, 2-thienyl group, 3-thienyl group, 2-methylpyrrole-1-yl group, 2-methylpyrrole-3-yl group , 2-methylpyrrole-4-yl group, 2-methylpyrrole-5-yl group, 3-methylpyrrole-1-yl group, 3-methylpyrrole-2-yl group, 3-methylpyrrole-4-yl group, 3-methylpyrrole -5-yl group, 2-t-butylpyrrole-4-yl group, 3- (2-phenylpropyl) pyrrol-1-yl group, 2-methyl-1-indolyl group, 4-methyl-1-indolyl group, 2- Methyl-3-indolyl group, 4-methyl-3-indolyl group, 2-t-butyl1-indolyl group, 4-t- Butyl-indolyl group, 2-t-butyl3-indolyl group and 4-t-butyl3-indolyl group.

또한, 실시예에서 사용된 용어 "치환 또는 비치환된 C1 -50 알킬기"의 예로서는, 메틸기, 에틸기, 프로필기, 아이소프로필기, n-뷰틸기, s-뷰틸기, 아이소뷰틸기, t-뷰틸기, n-펜틸기, n-헥실기, n-헵틸기, n-옥틸기, 하이드록시메틸기, 하이 드록시에틸기, 2-하이드록시에틸기, 2-하이드록시아이소뷰틸기, 1,2-다이하이드록시에틸기, 1,3-다이하이드록시아이소프로필기, 2,3-다이하이드록시-t-뷰틸기, 1,2,3-트라이하이드록시프로필기, 클로로메틸기, 1-클로로에틸기, 2-클로로에틸기, 2-클로로아이소뷰틸기, 1,2-다이클로로에틸기, 1,3-다이클로로아이소프로필기, 2,3-다이클로로-t-뷰틸기, 1,2,3-트라이클로로프로필기, 브로모메틸기, 1-브로모에틸기, 2-브로모에틸기, 2-브로모아이소뷰틸기, 1,2-다이브로모에틸기, 1,3-다이브로모아이소프로필기, 2,3-다이브로모-t-뷰틸기, 1,2,3-트라이브로모프로필기, 아이오도메틸기, 1-아이오도에틸기, 2-아이오도에틸기, 2-아이오도아이소뷰틸기, 1,2-다이아이오도에틸기, 1,3-다이아이오도아이소프로필기, 2,3-다이아이오도-t-뷰틸기, 1,2,3-트라이아이오도프로필기, 아미노메틸기, 1-아미노에틸기, 2-아미노에틸기, 2-아미노아이소뷰틸기, 1,2-다이아미노에틸기, 1,3-다이아미노아이소프로필기, 2,3-다이아미노-t-뷰틸기, 1,2,3-트라이아미노프로필기, 사이아노메틸기, 1-사이아노에틸기, 2-사이아노에틸기, 2-사이아노아이소뷰틸기, 1,2-다이사이아노에틸기, 1,3-다이사이아노아이소프로필기, 2,3-다이사이아노-t-뷰틸기, 1,2,3-트라이사이아노프로필기, 나이트로메틸기, 1-나이트로에틸기, 2-나이트로에틸기, 2-나이트로아이소뷰틸기, 1,2-다이나이트로에틸기, 1,3-다이나이트로아이소프로필기, 2,3-다이나이트로-t-뷰틸기, 1,2,3-트라이나이트로프로필기, 사이클로프로필기, 사이클로뷰틸기, 사이클로펜틸기, 사이클로헥실기, 4-메틸사이클로헥실기, 1-아다만틸기, 2-아다만틸기, 1-노보닐기 및 2-노보닐기 등일 수 있으나 이에 한정되지 않는다.Further, the terms used in the embodiment examples of the "substituted or unsubstituted C 1 -50 alkyl group", methyl group, ethyl group, propyl group, isopropyl group, n- views group, a s- views group, isobutoxy group, a t- Butyl group, n-pentyl group, n-hexyl group, n-heptyl group, n-octyl group, hydroxymethyl group, hydroxyethyl group, 2-hydroxyethyl group, 2-hydroxyisobutyl group, 1,2- Dihydroxyethyl group, 1,3-dihydroxyisopropyl group, 2,3-dihydroxy-t-butyl group, 1,2,3-trihydroxypropyl group, chloromethyl group, 1-chloroethyl group, 2 -Chloroethyl group, 2-chloroisobutyl group, 1,2-dichloroethyl group, 1,3-dichloroisopropyl group, 2,3-dichloro-t-butyl group, 1,2,3-trichloropropyl Group, bromomethyl group, 1-bromoethyl group, 2-bromoethyl group, 2-bromoisobutyl group, 1,2-dibromoethyl group, 1,3-dibromoisopropyl group, 2,3-dibromo- t-butyl group, 1, 2,3-tribromopropyl group, iodomethyl group, 1-iodoethyl group, 2-iodoethyl group, 2-iodoisobutyl group, 1,2-diiodoethyl group, 1,3-diiodoiso Propyl group, 2,3-diiodo-t-butyl group, 1,2,3-triiodopropyl group, aminomethyl group, 1-aminoethyl group, 2-aminoethyl group, 2-aminoisobutyl group, 1, 2-diaminoethyl group, 1,3-diaminoisopropyl group, 2,3-diamino-t-butyl group, 1,2,3-triaminopropyl group, cyanomethyl group, 1-cyanoethyl group, 2 -Cyanoethyl group, 2-cyanoisobutyl group, 1,2-dicyanoethyl group, 1,3-dicyanoisopropyl group, 2,3-dicyano-t-butyl group, 1,2, 3-tricyanopropyl group, nitromethyl group, 1-nitroethyl group, 2-nitroethyl group, 2-nitroisobutyl group, 1,2-dinitroethyl group, 1,3-dinitroisopropyl Flag, 2,3-dyna Low-t-butyl group, 1,2,3-trinitropropyl group, cyclopropyl group, cyclobutyl group, cyclopentyl group, cyclohexyl group, 4-methylcyclohexyl group, 1-adamantyl group, 2- Adamantyl, 1-norbornyl, 2-norbornyl, and the like, but are not limited thereto.

또한, 실시예에서 사용되는 용어 "치환 또는 비치환된 C1 -50의 알콕시기”는 -OR로 표시될 수 있으며, R의 예로서는, 메틸기, 에틸기, 프로필기, 아이소프로필기, n-뷰틸기, s-뷰틸기, 아이소뷰틸기, t-뷰틸기, n-펜틸기, n-헥실기, n-헵틸기, n-옥틸기, 하이드록시메틸기, 1-하이드록시에틸기, 2-하이드록시에틸기, 2-하이드록시아이소뷰틸기, 1,2-다이하이드록시에틸기, 1,3-다이하이드록시아이소프로필기, 2,3-다이하이드록시-t-뷰틸기, 1,2,3-트라이하이드록시프로필기, 클로로메틸기, 1-클로로에틸기, 2-클로로에틸기, 2-클로로아이소뷰틸기, 1,2-다이클로로에틸기, 1,3-다이클로로아이소프로필기, 2,3-다이클로로-t-뷰틸기, 1,2,3-트라이클로로프로필기, 브로모메틸기, 1-브로모에틸기, 2-브로모에틸기, 2-브로모아이소뷰틸기, 1,2-다이브로모에틸기, 1,3-다이브로모아이소프로필기, 2,3-다이브로모-t-뷰틸기, 1,2,3-트라이브로모프로필기, 아이오도메틸기, 1-아이오도에틸기, 2-아이오도에틸기, 2-아이오도아이소뷰틸기, 1,2-다이아이오도에틸기, 1,3-다이아이오도아이소프로필기, 2,3-다이아이오도-t-뷰틸기, 1,2,3-트라이아이오도프로필기, 아미노메틸기, 1-아미노에틸기, 2-아미노에틸기, 2-아미노아이소뷰틸기, 1,2-다이아미노에틸기, 1,3-다이아미노아이소프로필기, 2,3-다이아미노-t-뷰틸기, 1,2,3-트라이아미노프로필기, 사이아노메틸기, 1-사이아노에틸기, 2-사이아노에틸기, 2-사이아노아이소뷰틸기, 1,2-다이사이아노에틸기, 1,3-다이사이아노아이소프로필기, 2,3-다이사이아노-t-뷰틸기, 1,2,3-트라이사이아노프로필기, 나이트로메틸기, 1-나이트로에틸기, 2-나이트로에틸기, 2-나이트로아이소뷰틸기, 1,2-다이나이트로에틸기, 1,3-다 이나이트로아이소프로필기, 2,3-다이나이트로-t-뷰틸기 및 1,2,3-트라이나이트로프로필기 등일 수 있으나 이에 한정되지 않는다.Further, in terms that are used in for example, "alkoxy group of a substituted or unsubstituted C 1 -50" may be represented by -OR, and examples of R, a methyl group, an ethyl group, a propyl group, an isopropyl group, an n- view group , s-butyl group, isobutyl group, t-butyl group, n-pentyl group, n-hexyl group, n-heptyl group, n-octyl group, hydroxymethyl group, 1-hydroxyethyl group, 2-hydroxyethyl group , 2-hydroxyisobutyl group, 1,2-dihydroxyethyl group, 1,3-dihydroxyisopropyl group, 2,3-dihydroxy-t-butyl group, 1,2,3-trihydroxy Roxypropyl group, chloromethyl group, 1-chloroethyl group, 2-chloroethyl group, 2-chloroisobutyl group, 1,2-dichloroethyl group, 1,3-dichloroisopropyl group, 2,3-dichloro-t -Butyl group, 1,2,3-trichloropropyl group, bromomethyl group, 1-bromoethyl group, 2-bromoethyl group, 2-bromoisobutyl group, 1,2-dibromoethyl group, 1,3- Dibromoai Propyl group, 2,3-dibromo-t-butyl group, 1,2,3-tribromopropyl group, iodomethyl group, 1-iodoethyl group, 2-iodoethyl group, 2-iodoisobutyl group, 1,2-diiodoethyl group, 1,3-diiodoisopropyl group, 2,3-diiodo-t-butyl group, 1,2,3-triiodopropyl group, aminomethyl group, 1- Aminoethyl group, 2-aminoethyl group, 2-aminoisobutyl group, 1,2-diaminoethyl group, 1,3-diaminoisopropyl group, 2,3-diamino-t-butyl group, 1,2,3 -Triaminopropyl group, cyanomethyl group, 1-cyanoethyl group, 2-cyanoethyl group, 2-cyanoisobutyl group, 1,2-dicyanoethyl group, 1,3- dicyanoisopropyl group, 2,3-dicyano-t-butyl group, 1,2,3-tricyanopropyl group, nitromethyl group, 1-nitroethyl group, 2-nitroethyl group, 2-nitroisobutyl group, 1 , 2-diethyl ethyl, 1,3-di Bytes, isopropyl group, 2,3-nitro -t- view or the like, but a group profile group, and 1,2,3-tri-nitro not limited to this.

또한, 실시예에서 사용된 용어 "치환 또는 비치환된 C4 -60의 아릴옥시기"는 - OY'로 표시될 수 있으며, Y'의 예로서는 페닐기, 1-나프틸기, 2-나프틸기, 1-안트릴기, 2-안트릴기, 9-안트릴기, 1-페난트릴기, 2-페난트릴기, 3-페난트릴기, 4-페난트릴기, 9-페난트릴기, 1-나프타센일기, 2-나프타센일기, 9-나프타센일기, 1-피렌일기, 2-피렌일기, 4-피렌일기, 2-바이페닐일기, 3-바이페닐일기, 4-바이페닐일기, p-터페닐-4-일기, p-터페닐-3-일기, p-터페닐-2-일기, m-터페닐-4-일기, m-터페닐-3-일기, m-터페닐-2-일기, o-톨릴기, m-톨릴기, p-톨릴기, p-t-뷰틸페닐기, p-(2-페닐프로필)페닐기, 3-메틸-2-나프틸기, 4-메틸-1-나프틸기, 4-메틸-1-안트릴기, 4'-메틸바이페닐일기, 4"-t-뷰틸-p-터페닐-4-일기, 2-피롤릴기, 3-피롤릴기, 피라진일기, 2-피리딘일기, 3-피리딘일기, 4-피리딘일기, 2-인돌릴기, 3-인돌릴기, 4-인돌릴기, 5-인돌릴기, 6-인돌릴기, 7-인돌릴기, 1-아이소인돌릴기, 3-아이소인돌릴기, 4-아이소인돌릴기, 5-아이소인돌릴기, 6-아이소인돌릴기, 7-아이소인돌릴기, 2-퓨릴기, 3-퓨릴기, 2-벤조퓨란일기, 3-벤조퓨란일기, 4-벤조퓨란일기, 5-벤조퓨란일기, 6-벤조퓨란일기, 7-벤조퓨란일기, 1-아이소벤조퓨란일기, 3-아이소벤조퓨란일기, 4-아이소벤조퓨란일기, 5-아이소벤조퓨란일기, 6-아이소벤조퓨란일기, 7-아이소벤조퓨란일기, 2-퀴놀릴기, 3-퀴놀릴기, 4-퀴놀릴기, 5-퀴놀릴기, 6-퀴놀릴기, 7-퀴놀릴기, 8-퀴놀릴기, 1-아이소퀴놀릴기, 3-아이소퀴놀릴기, 4-아이소퀴 놀릴기, 5-아이소퀴놀릴기, 6-아이소퀴놀릴기, 7-아이소퀴놀릴기, 8-아이소퀴놀린기, 2-퀴녹살린일기, 5-퀴녹살린일기, 6-퀴녹살린일기, 1-카바졸릴기, 2-카바졸릴기, 3-카바졸릴기, 4-카바졸릴기, 1-페난트리딘일기, 2-페난트리딘일기, 3-페난트리딘일기, 4-페난트리딘일기, 6-페난트리딘일기, 7-페난트리딘일기, 8-페난트리딘일기, 9-페난트리딘일기, 10-페난트리딘일기, 1-아크리딘일기, 2-아크리딘일기, 3-아크리딘일기, 4-아크리딘일기, 9-아크리딘일기, 1,7-페난트롤린-2-일기, 1,7-페난트롤린-3-일기, 1,7-페난트롤린-4-일기, 1,7-페난트롤린-5-일기, 1,7-페난트롤린-6-일기, 1,7-페난트롤린-8-일기, 1,7-페난트롤린-9-일기, 1,7-페난트롤린-10-일기, 1,8-페난트롤린-2-일기, 1,8-페난트롤린-3-일기, 1,8-페난트롤린-4-일기, 1,8-페난트롤린-5-일기, 1,8-페난트롤린-6-일기, 1,8-페난트롤린-7-일기, 1,8-페난트롤린-9-일기, 1,8-페난트롤린-10-일기, 1,9-페난트롤린-2-일기, 1,9-페난트롤린-3-일기, In addition, the term "substituted or unsubstituted aryloxy group of C 4 -60 " used in the examples may be represented by -OY ', and as examples of Y', a phenyl group, 1-naphthyl group, 2-naphthyl group, 1 -Anthryl group, 2-Anthryl group, 9-Anthryl group, 1-phenanthryl group, 2-phenanthryl group, 3-phenanthryl group, 4-phenanthryl group, 9-phenanthryl group, 1-naphtha Senyl group, 2-naphthacenyl group, 9-naphthacenyl group, 1-pyrenyl group, 2-pyrenyl group, 4-pyrenyl group, 2-biphenylyl group, 3-biphenylyl group, 4-biphenylyl group, p- Terphenyl-4-yl group, p-terphenyl-3-yl group, p-terphenyl-2-yl group, m-terphenyl-4-yl group, m-terphenyl-3-yl group, m-terphenyl-2- Diary, o-tolyl group, m-tolyl group, p-tolyl group, pt-butylphenyl group, p- (2-phenylpropyl) phenyl group, 3-methyl-2-naphthyl group, 4-methyl-1-naphthyl group, 4-methyl-1-anthryl group, 4'-methylbiphenylyl group, 4 "-t-butyl-p-terphenyl-4-yl group, 2-pyrrolyl group, 3-pyrrolyl group, pyrazinyl group, 2-pyridine Diary, 3-pyridinyl, 4-pyridinyl, 2-indolyl , 3-indolyl group, 4-indolyl group, 5-indolyl group, 6-indolyl group, 7-indolyl group, 1-isoindoleyl group, 3-isoindolyl group, 4-isoindolinyl group, 5-iso Soindolyl group, 6-isoindoleyl group, 7-isoindoleyl group, 2-furyl group, 3-furyl group, 2-benzofuranyl group, 3-benzofuranyl group, 4-benzofuranyl group, 5-benzofuran Diary, 6-benzofuranyl group, 7-benzofuranyl group, 1-isobenzofuranyl group, 3-isobenzofuranyl group, 4-isobenzofuranyl group, 5-isobenzofuranyl group, 6-isobenzofuranyl group, 7 Isobenzofuranyl group, 2-quinolyl group, 3-quinolyl group, 4-quinolyl group, 5-quinolyl group, 6-quinolyl group, 7-quinolyl group, 8-quinolyl group, 1- Isoquinolyl, 3-isoquinolyl, 4-isoquinolyl, 5-isoquinolyl, 6-isoquinolyl, 7-isoquinolyl, 8-isoquinoline, 2-quinoxaline Diary, 5-quinoxalineyl, 6-quinoxalineyl, 1-carbazolyl, 2-carbazolyl, 3-carbazolyl, 4-carbazole Group, 1-phenanthridinyl group, 2-phenanthridinyl group, 3-phenanthridinyl group, 4-phenanthridinyl group, 6-phenanthridinyl group, 7-phenanthridinyl group, 8-phenanthridinyl group , 9-phenanthridinyl group, 10-phenanthridinyl group, 1-acridinyl group, 2-acridinyl group, 3-acridinyl group, 4-acridinyl group, 9-acridinyl group, 1,7-phenanthroline-2-yl, 1,7-phenanthroline-3-yl, 1,7-phenanthroline-4-yl, 1,7-phenanthroline-5-diary, 1, 7-phenanthroline-6-diary, 1,7-phenanthroline-8-diary, 1,7-phenanthroline-9-diary, 1,7-phenanthroline-10-diary, 1,8- Phenanthroline-2-yl, 1,8-phenanthroline-3-yl, 1,8-phenanthroline-4-yl, 1,8-phenanthroline-5-diary, 1,8-phenanthrole Lin-6-diary, 1,8-phenanthroline-7-diary, 1,8-phenanthroline-9-diary, 1,8-phenanthroline-10-diary, 1,9-phenanthroline- 2-diary, 1,9-phenanthroline-3-yl,

1,9-페난트롤린-4-일기, 1,9-페난트롤린-5-일기, 1,9-페난트롤린-6-일기, 1,9-페난트롤린-7-일기, 1,9-페난트롤린-8-일기, 1,9-페난트롤린-10-일기, 1,10-페난트롤린-2-일기, 1,10-페난트롤린-3-일기, 1,10-페난트롤린-4-일기, 1,10-페난트롤린-5-일기, 2,9-페난트롤린-1-일기, 2,9-페난트롤린-3-일기, 2,9-페난트롤린-4-일기, 2,9-페난트롤린-5-일기, 2,9-페난트롤린-6-일기, 2,9-페난트롤린-7-일기, 2,9-페난트롤린-8-일기, 2,9-페난트롤린-10-일기, 2,8-페난트롤린-1-일기, 2,8-페난트롤린-3-일기, 2,8-페난트롤린-4-일기, 2,8-페난트롤린-5-일기, 2,8-페난트롤린-6-일기, 2,8-1,9-phenanthroline-4-yl, 1,9-phenanthroline-5-diary, 1,9-phenanthroline-6-diary, 1,9-phenanthroline-7-diary, 1, 9-phenanthroline-8-diary, 1,9-phenanthroline-10-diary, 1,10-phenanthroline-2-yl, 1,10-phenanthroline-3-yl, 1,10- Phenanthroline-4-yl, 1,10-phenanthroline-5-yl, 2,9-phenanthroline-1-yl, 2,9-phenanthroline-3-yl, 2,9-phenanthrole Lin-4-yl, 2,9-phenanthroline-5-diary, 2,9-phenanthroline-6-diary, 2,9-phenanthroline-7-diary, 2,9-phenanthroline- 8-diary, 2,9-phenanthroline-10-diary, 2,8-phenanthroline-1-yl, 2,8-phenanthroline-3-yl, 2,8-phenanthroline-4- Diary, 2,8-phenanthroline-5-diary, 2,8-phenanthroline-6-diary, 2,8-

페난트롤린-7-일기, 2,8-페난트롤린-9-일기, 2,8-페난트롤린-10-일기, 2,7-페난트롤린-1-일기, 2,7-페난트롤린-3-일기, 2,7-페난트롤린-4-일기, 2,7-페난트롤린-5- 일기, 2,7-페난트롤린-6-일기, 2,7-페난트롤린-8-일기, 2,7-페난트롤린-9-일기, 2,7-페난트롤린-10-일기, 1-페나진일기, 2-페나진일기, 1-페노싸이아진일기, 2-페노싸이아진일기, 3-페노싸이아진일기, 4-페노싸이아진일기, 1-페녹사진일기, 2-페녹사진일기, 3-페녹사진일기, 4-페녹사진일기, 2-옥사졸릴기, 4-옥사졸릴기, 5-옥사졸릴기, 2-옥사다이아졸릴기, 5-옥사다이아졸릴기, 3-퓨라잔일기, 2-싸이엔일기, 3-싸이엔일기, 2-메틸피롤-1-일기, 2-메틸피롤-3-일기, 2-메틸피롤-4-일기, 2-메틸피롤-5-일기, 3-메틸피롤-1-일기, 3-메틸피롤-2-일기, 3-메틸피롤-4-일기, 3-메틸피롤-5-일기, 2-t-뷰틸피롤-4-일기, 3-(2-페닐프로필)피롤-1-일기, 2-메틸-1-인돌릴기, 4-메틸-1-인돌릴기, 2-메틸-3-인돌릴기, 4-메틸-3-인돌릴기, 2-t-뷰틸1-인돌릴기, 4-t-뷰틸1-인돌릴기, 2-t-뷰틸3-인돌릴기 및 4-t-뷰틸3-인돌릴기 등일 수 있으나 이에 한정되지 않는다.Phenanthroline-7-diary, 2,8-phenanthroline-9-diary, 2,8-phenanthroline-10-diary, 2,7-phenanthroline-1-diary, 2,7-phenanthrole Lin-3-yl, 2,7-phenanthroline-4-yl, 2,7-phenanthroline-5-diary, 2,7-phenanthroline-6-diary, 2,7-phenanthroline- 8-diary, 2,7-phenanthroline-9-diary, 2,7-phenanthroline-10-diary, 1-phenazineyl group, 2-phenazineyl group, 1-phenothiazinyl group, 2-pheno Thiazin diary, 3-phenothiazin diary, 4-phenothiazin diary, 1-phenoxazine diary, 2-phenoxazine diary, 3-phenoxazine diary, 4-phenoxazine diary, 2-oxazolyl group, 4- Oxazolyl group, 5-oxazolyl group, 2-oxadiazolyl group, 5-oxadiazolyl group, 3-furazanyl group, 2-thienyl group, 3-thienyl group, 2-methylpyrrole-1-yl group , 2-methylpyrrole-3-yl group, 2-methylpyrrole-4-yl group, 2-methylpyrrole-5-yl group, 3-methylpyrrole-1-yl group, 3-methylpyrrole-2-yl group, 3-methylpyrrole -4-yl group, 3-methylpyrrole-5-yl group, 2-t-butylpyrrole-4-yl group, 3- (2-phenylpropyl) pyrrol-1-yl group , 2-methyl-1-indolyl group, 4-methyl-1-indolyl group, 2-methyl-3-indolyl group, 4-methyl-3-indolyl group, 2-t-butyl1-indolyl group, 4-t -Butyl 1-indolyl group, 2-t- butyl 3- indolyl group, 4-t- butyl 3- indolyl group and the like, but is not limited thereto.

또한, 실시예에서 사용되는 용어 "알킬싸이오기”는 -SR로 표시될 수 있으며, R은 앞서 정의된 바와 같다.In addition, the term "alkylthio" used in the examples may be represented by -SR, and R is as defined above.

또한, 실시예에서 사용된 "아릴싸이오기”는 - SY’로 표시될 수 있으며, Y'는 앞서 정의된 바와 같다.In addition, "arylthio group" used in the embodiment may be represented by-SY ', Y' is as defined above.

또한, 실시예에서 사용된 "-N(Ar5)2 또는 -N(Ar5)(Ar6)로 표현되는 치환 또는 비치환된 아미노기"는 앞서 표현된 Ar1 내지 Ar3로 정의된 바와 같다.In addition, the "substituted or unsubstituted amino group represented by -N (Ar 5 ) 2 or -N (Ar 5 ) (Ar 6 )" used in the examples is as defined above with Ar 1 to Ar 3 . .

또한, 실시예에서 사용된 용어 "할로겐 원자"는 불소, 염소, 브롬 및 요오드 등일 수 있으나 이에 한정되지 않는다.In addition, the term "halogen atom" used in the examples may be, but is not limited to, fluorine, chlorine, bromine and iodine.

본 발명의 실시예에 따른 화합물의 구체적 예로써, 화학식 1에 속하는 아래 화학식 2의 화합물들이 있으나, 본 발명은 이들에만 한정되는 것은 아니다.As a specific example of the compound according to an embodiment of the present invention, there are compounds of the formula (2) belonging to the formula (1), but the present invention is not limited thereto.

Figure 112009018902968-pat00003
Figure 112009018902968-pat00003

본 발명의 실시예에 따른 화합물의 구체적 예로써, 화학식 1에 속하는 아래 화학식 3의 화합물들이 있으나, 본 발명은 이들에만 한정되는 것은 아니다.As a specific example of the compound according to an embodiment of the present invention, there are compounds of the formula (3) belonging to the formula (1), but the present invention is not limited thereto.

Figure 112009018902968-pat00004
Figure 112009018902968-pat00004

본 발명의 실시예에 따른 화합물의 구체적 예로써, 화학식 1에 속하는 아래 화학식 4의 화합물들이 있으나, 본 발명은 이들에만 한정되는 것은 아니다.As a specific example of a compound according to an embodiment of the present invention, there are compounds of the formula (4) belonging to the formula (1), but the present invention is not limited thereto.

Figure 112009018902968-pat00005
Figure 112009018902968-pat00005

화학식 1 내지 4를 참조하여 설명한 화합물들이 유기물층으로 사용되는 다양한 유기전자소자들이 존재한다. 화학식 1 내지 4를 참조하여 설명한 화합물들이 사용될 수 있는 유기전자소자는 예를 들어, 유기전계발광소자(OLED), 유기태양전지, 유기감광체(OPC) 드럼, 유기트랜지스트(유기 TFT), 포토다이오드(photodiode), 유기레이저(organic laser), 레이저 다이오드(laser diode) 등 유기반도체 물질을 사용될 수 있다.Various organic electronic devices exist in which the compounds described with reference to Chemical Formulas 1 to 4 are used as the organic material layer. Examples of the organic electronic device in which the compounds described with reference to Chemical Formulas 1 to 4 may be used include, for example, an organic light emitting diode (OLED), an organic solar cell, an organic photoconductor (OPC) drum, an organic transistor (organic TFT), and a photodiode. Organic semiconductor materials such as photodiode, organic laser, and laser diode may be used.

화학식 1 내지 4를 참조하여 설명한 화합물들이 적용될 수 있는 유기전자소자 중 일예로 유기전계발광소자(OLED)에 대하여 아래와 같이 설명하나 본 발명은 이에 제한되지 않고 다양한 유기전자소자들에 위에서 설명한 화합물이 적용될 수 있다.As an example, among the organic electronic devices to which the compounds described with reference to Chemical Formulas 1 to 4 may be applied, the organic light emitting diode (OLED) will be described below. The present invention is not limited thereto, and the compounds described above may be applied to various organic electronic devices. Can be.

본 발명의 다른 실시예는 제1 전극, 제2 전극 및 이들 전극 사이에 배치된 유기물층을 포함하는 유기전자소자에 있어서, 상기 유기물층 중 1층 이상이 상기 화학식 1 내지 4의 화합물들을 포함하는 유기전계발광소자를 제공한다.Another embodiment of the present invention is an organic electronic device comprising a first electrode, a second electrode and an organic material layer disposed between these electrodes, at least one of the organic material layer of the organic electric field comprising the compounds of Formula 1 to 4 Provided is a light emitting device.

본 발명의 다른 실시예에 따른 유기전계발광소자는, 정공주입층, 정공수송층, 발광층 및 전자수송층을 포함하는 유기물층 중 1층 이상을 상기 화학식 1 내지 4의 화합물들을 포함하도록 형성하는 것을 제외하고는, 당 기술 분야에 통상의 제조 방법 및 재료를 이용하여 당 기술 분야에 알려져 있는 구조로 제조될 수 있다. 본 발명에 따른 유기전계발광소자의 구조는 도 1 내지 5에 예시되어 있으나, 이들 구조에만 한정된 것은 아니다. 이때, 도면번호 101은 기판, 102는 양극, 103는 정공주입층, 104는 정공전달츨, 105는 발광층, 106은 전자주입층, 107은 음극을 나타낸다.An organic light emitting display device according to another embodiment of the present invention, except that at least one layer of the organic material layer including a hole injection layer, a hole transport layer, a light emitting layer and an electron transport layer to form the compound of Formula 1 to 4 to include It can be prepared in a structure known in the art using conventional manufacturing methods and materials in the art. The structure of the organic light emitting display device according to the present invention is illustrated in FIGS. 1 to 5, but is not limited thereto. In this case, reference numeral 101 denotes a substrate, 102 an anode, 103 a hole injection layer, 104 a hole transport layer, 105 a light emitting layer, 106 an electron injection layer, and 107 a cathode.

화학식 1 내지 4를 참조하여 설명한 화합물들은 정공주입층 및 정공수송층 중 하나 이상에 포함될 수 있다. 구체적으로, 화학식 1 내지 4를 참조하여 설명한 화합물들은 아래에서 설명한 정공주입층 및 정공수송층, 발광층 및 전자수송층 중 하나 이상을 대신하여 사용되거나 이들과 함께 층을 형성하여 사용될 수도 있다. 물론 유기물층 중 한 층에만 사용되는 것이 아니라 두 층 이상에 사용될 수 있다.Compounds described with reference to Formulas 1 to 4 may be included in one or more of a hole injection layer and a hole transport layer. Specifically, the compounds described with reference to Formulas 1 to 4 may be used in place of one or more of the hole injection layer, the hole transport layer, the light emitting layer, and the electron transport layer described below, or may be used by forming a layer with them. Of course, it is not only used in one layer of the organic material layer but may be used in two or more layers.

특히, 화학식 1 내지 4를 참조하여 설명한 화합물들은 발광층, 예를 들어 청색 또는 녹색, 적색 발광층(형광물질) 중 하나 또는 하나 이상에 각각 기존의 물질을 대신하거나 기존의 물질들과 함께 해당 층을 형성할 수도 있다.In particular, the compounds described with reference to Chemical Formulas 1 to 4 replace the existing materials or form the corresponding layers with one or more of the light emitting layers, for example, blue, green, and red light emitting layers (fluorescent materials), respectively. You may.

예컨대, 본 발명의 다른 실시예에 따른 유기전계발광소자는 스퍼터링(sputtering)이나 전자빔 증발(e-beam evaporation)과 같은 PVD(physical vapor deposition) 방법을 이용하여, 기판 상에 금속 또는 전도성을 가지는 금속 산화물 또는 이들의 합금을 증착시켜 양극을 형성하고, 그 위에 정공주입층, 정공수송층, 발광층 및 전자수송층을 포함하는 유기물층을 형성한 후, 그 위에 음극으로 사용할 수 있는 물질을 증착시킴으로써 제조될 수 있다.For example, the organic light emitting device according to another embodiment of the present invention is a metal having a metal or conductivity on a substrate by using a physical vapor deposition (PVD) method such as sputtering or e-beam evaporation It can be prepared by depositing an oxide or an alloy thereof to form an anode, forming an organic material layer including a hole injection layer, a hole transport layer, a light emitting layer and an electron transport layer thereon, and then depositing a material that can be used as a cathode thereon. .

이와 같은 방법 외에도, 기판 상에 음극 물질부터 유기물층, 양극 물질을 차례로 증착시켜 유기전자소자를 만들 수도 있다. 상기 유기물층은 정공주입층, 정공수송층, 발광층 및 전자수송층 등을 포함하는 다층 구조일 수도 있으나, 이에 한정되지 않고 단층 구조일 수 있다. 또한, 상기 유기물층은 다양한 고분자 소재를 사용하여 증착법이 아닌 솔벤트 프로세스(solvent process), 예컨대 스핀 코팅, 딥 코팅, 닥터 블레이딩, 스크린 프린팅, 잉크젯 프린팅 또는 열 전사법 등의 방법에 의하여 더 적은 수의 층으로 제조할 수 있다. In addition to the above method, an organic electronic device may be manufactured by sequentially depositing a cathode material, an organic material layer, and an anode material on a substrate. The organic material layer may have a multilayer structure including a hole injection layer, a hole transport layer, a light emitting layer, and an electron transport layer, but is not limited thereto and may have a single layer structure. In addition, the organic material layer may be formed using a variety of polymer materials by a solvent process such as a spin coating process, a dip coating process, a doctor blading process, a screen printing process, an inkjet printing process or a thermal transfer process, Layer.

본 발명의 다른 실시예에 따른 유기전계발광소자는 위에서 설명한 화합물들을 용액 공정(soluble process)에 의해 유기물층, 예를 들어 발광층을 형성할 수도 있다. The organic light emitting device according to another embodiment of the present invention may form an organic material layer, for example, a light emitting layer, by the soluble process of the compounds described above.

기판은 유기전계발광소자의 지지체이며, 실리콘 웨이퍼, 석영 또는 유리판, 금속판, 플라스틱 필름이나 시트 등이 사용될 수 있다.The substrate is a support of the organic light emitting device, and a silicon wafer, quartz or glass plate, metal plate, plastic film or sheet, or the like can be used.

기판 위에는 양극이 위치된다. 이러한 양극은 그 위에 위치되는 정공주입층으로 정공을 주입한다. 양극 물질로는 통상 유기물층으로 정공주입이 원활할 수 있도록 일함수가 큰 물질이 바람직하다. 본 발명에서 사용될 수 있는 양극 물질의 구체적인 예로는 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금; 아연산화물, 인듐산화물, 인듐주석 산화물(ITO), 인듐아연산화물(IZO)과 같은 금속 산화물; ZnO:Al 또는 SnO2:Sb와 같은 금속과 산화물의 조합; 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDT), 폴리피롤 및 폴리아닐린과 같은 전도성 고분자 등이 있으나, 이들에만 한정되는 것은 아니다. An anode is positioned over the substrate. This anode injects holes into the hole injection layer located thereon. As the anode material, a material having a large work function is usually preferred to facilitate hole injection into the organic material layer. Specific examples of the positive electrode material that can be used in the present invention include metals such as vanadium, chromium, copper, zinc and gold or alloys thereof; Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); ZnO: Al or SnO 2: a combination of a metal and an oxide such as Sb; Conductive polymers such as poly (3-methylthiophene), poly [3,4- (ethylene-1,2-dioxy) thiophene] (PEDT), polypyrrole and polyaniline.

양극 위에는 정공주입층이 위치된다. 이러한 정공주입층의 물질로 요구되는 조건은 양극으로부터의 정공주입 효율이 높으며, 주입된 정공을 효율적으로 수송할 수 있어야 한다. 이를 위해서는 이온화 포텐셜이 작고 가시광선에 대한 투명성이 높으며, 정공에 대한 안정성이 우수해야 한다.The hole injection layer is located on the anode. The conditions required for the material of the hole injection layer are high hole injection efficiency from the anode, it should be able to transport the injected holes efficiently. This requires a small ionization potential, high transparency to visible light, and excellent hole stability.

정공주입 물질로는 낮은 전압에서 양극으로부터 정공을 잘 주입받을 수 있는 물질로서, 정공주입 물질의 HOMO(highest occupied molecular orbital)가 양극 물질의 일함수와 주변 유기물층의 HOMO 사이인 것이 바람직하다. 정공주입 물질의 구체적인 예로는 금속 포피린(porphyrine), 올리고티오펜, 아릴아민 계열의 유기물, 헥사니트릴 헥사아자트리페닐렌, 퀴나크리돈(quinacridone) 계열의 유기물, 페릴 렌(perylene) 계열의 유기물, 안트라퀴논 및 폴리아닐린과 폴리티오펜 계열의 전도성 고분자 등이 있으나, 이들에만 한정되는 것은 아니다.As the hole injecting material, it is preferable that the highest occupied molecular orbital (HOMO) of the hole injecting material be between the work function of the anode material and the HOMO of the surrounding organic layer. Specific examples of the hole injection material include metal porphyrine, oligothiophene, arylamine-based organics, hexanitrile hexaazatriphenylene, quinacridone-based organics, perylene-based organics, Anthraquinone, polyaniline and polythiophene-based conductive polymers, but are not limited thereto.

상기 정공주입층 위에는 정공수송층이 위치된다. 이러한 정공수송층은 정공주입층으로부터 정공을 전달받아 그 위에 위치되는 유기발광층으로 수송하는 역할을 하며, 높은 정공 이동도와 정공에 대한 안정성 및 전자를 막아주는 역할를 한다. 이러한 일반적 요구 이외에 차체 표시용으로 응용할 경우 소자에 대한 내열성이 요구되며, 유리 전이 온도(Tg)가 70 ℃ 이상의 값을 갖는 재료가 바람직하다. 이와 같은 조건을 만족하는 물질들로는 NPD(혹은 NPB라 함), 스피로-아릴아민계화합물, 페릴렌-아릴아민계화합물, 아자시클로헵타트리엔화합물, 비스(디페닐비닐페닐)안트라센, 실리콘게르마늄옥사이드화합물, 실리콘계아릴아민화합물 등이 있다.The hole transport layer is positioned on the hole injection layer. The hole transport layer receives holes from the hole injection layer and transports the holes to the organic light emitting layer located thereon, and serves to prevent high hole mobility, hole stability, and electrons. In addition to these general requirements, when applied for vehicle body display, heat resistance to the device is required, and a material having a glass transition temperature (Tg) of 70 ° C. or higher is preferable. Materials satisfying these conditions include NPD (or NPB), spiro-arylamine compounds, perylene-arylamine compounds, azacycloheptatriene compounds, bis (diphenylvinylphenyl) anthracene and silicon germanium oxide. Compounds, silicone arylamine compounds and the like.

정공수송층 위에는 유기발광층이 위치된다. 이러한 유기발광층는 양극과 음극으로부터 각각 주입된 정공과 전자가 재결합하여 발광을 하는 층이며, 양자효율이 높은 물질로 이루어져 있다. 발광 물질로는 정공수송층과 전자수송층으로부터 정공과 전자를 각각 수송받아 결합시킴으로써 가시광선 영역의 빛을 낼 수 있는 물질로서, 형광이나 인광에 대한 양자효율이 좋은 물질이 바람직하다. The organic light emitting layer is positioned on the hole transport layer. The organic light emitting layer is a layer for emitting light by recombination of holes and electrons injected from the anode and the cathode, respectively, and is made of a material having high quantum efficiency. The light emitting material is a material capable of emitting light in the visible region by transporting and combining holes and electrons from the hole transport layer and the electron transport layer, respectively, and a material having good quantum efficiency with respect to fluorescence or phosphorescence is preferable.

이와 같은 조건을 만족하는 물질 또는 화합물로는 녹색의 경우 Alq3가, 청색의 경우 Balq(8-hydroxyquinoline beryllium salt), DPVBi(4,4'-bis(2,2-diphenylethenyl)-1,1'-biphenyl) 계열, 스피로(Spiro) 물질, 스피로-DPVBi(Spiro-4,4'-bis(2,2-diphenylethenyl)-1,1'-biphenyl), LiPBO(2-(2-benzoxazoyl)-phenol lithium salt), 비스(디페닐비닐페닐비닐)벤젠, 알루미늄-퀴놀린 금속착체, 이미다 졸, 티아졸 및 옥사졸의 금속착체 등이 있으며, 청색 발광 효율을 높이기 위해 페릴렌, 및 BczVBi(3,3'[(1,1'-biphenyl)-4,4'-diyldi-2,1-ethenediyl]bis(9-ethyl)-9H-carbazole; DSA(distrylamine)류)를 소량 도핑하여 사용할 수 있다. 적색의 경우는 녹색 발광 물질에 DCJTB([2-(1,1-dimethylethyl)-6-[2-(2,3,6,7-tetrahydro-1,1,7,7-tetramethyl-1H,5H-benzo(ij)quinolizin-9-yl)ethenyl]-4H-pyran-4-ylidene]-propanedinitrile)와 같은 물질을 소량 도핑하여 사용한다. 잉크젯프린팅, 롤코팅, 스핀코팅 등의 공정을 사용하여 발광층을 형성할 경우에, 폴리페닐렌비닐렌(PPV) 계통의 고분자나 폴리 플로렌(poly fluorene) 등의 고분자를 유기발광층에 사용할 수 있다.Substances or compounds that satisfy these conditions include Alq3 for green, Balq (8-hydroxyquinoline beryllium salt) for blue, DPVBi (4,4'-bis (2,2-diphenylethenyl) -1,1'- biphenyl) series, Spiro material, Spiro-DPVBi (Spiro-4,4'-bis (2,2-diphenylethenyl) -1,1'-biphenyl), LiPBO (2- (2-benzoxazoyl) -phenol lithium salt), bis (diphenylvinylphenylvinyl) benzene, aluminum-quinoline metal complex, metal complexes of imidazole, thiazole and oxazole, and the like, perylene, and BczVBi (3,3) in order to increase blue light emission efficiency. A small amount of '[(1,1'-biphenyl) -4,4'-diyldi-2,1-ethenediyl] bis (9-ethyl) -9H-carbazole; DSA (distrylamine) can be used. In the case of red, DCJTB ([2- (1,1-dimethylethyl) -6- [2- (2,3,6,7-tetrahydro-1,1,7,7-tetramethyl-1H, 5H A small amount of doping such as -benzo (ij) quinolizin-9-yl) ethenyl] -4H-pyran-4-ylidene] -propanedinitrile) is used. When forming a light emitting layer using a process such as inkjet printing, roll coating, or spin coating, a polymer of polyphenylene vinylene (PPV) -based polymer or poly fluorene may be used for the organic light emitting layer. .

앞에서 설명한 바와 같이 화학식 1 내지 4를 참조하여 설명한 화합물들은 발광층, 예를 들어 청색 또는 녹색, 적색 발광층 중 하나 또는 하나 이상에 각각 기존의 물질을 대신하거나 기존의 물질들과 함께 해당 층을 형성할 수도 있다.As described above, the compounds described with reference to Chemical Formulas 1 to 4 may replace the existing materials or form the corresponding layers with the existing materials in one or more of the light emitting layers, for example, the blue, green, and red light emitting layers, respectively. have.

앞에서 설명한 바와 같이 화학식 1 내지 4를 참조하여 설명한 화합물들은 합성된 화합물에 따라서 적색, 녹색, 청색, 흰색 등의 모든 칼라의 인광 소자에 적합한 정공주입 재료 및 정공수송 재료 중 하나 이상의 재료로 사용될 수 있다. As described above, the compounds described with reference to Chemical Formulas 1 to 4 may be used as one or more of a hole injection material and a hole transport material suitable for phosphorescent devices of all colors, such as red, green, blue, and white, depending on the synthesized compound. .

예를 들어, 화학식 1 내지 4를 참조하여 설명한 화합물들은 다양한 칼라의 인광 도판트 호스트 물질로 사용될 수 있다.For example, the compounds described with reference to Formulas 1-4 may be used as phosphorescent dopant host materials of various colors.

유기발광층 위에는 전자수송층이 위치된다. 이러한 전자수송층은 그 위에 위치되는 음극으로부터 전자주입 효율이 높고 주입된 전자를 효율적으로 수송할 수 있는 물질이 필요하다. 이를 위해서는 전자 친화력과 전자 이동속도가 크고 전자에 대한 안정성이 우수한 물질로 이루어져야 한다. 이와 같은 조건을 충족시키는 전자수송 물질로는 구체적인 예로 8-히드록시퀴놀린의 Al 착물; Alq3를 포함한 착물; 유기 라디칼 화합물; 히드록시플라본-금속 착물 등이 있으나, 이들에만 한정되는 것은 아니다. The electron transport layer is positioned on the organic light emitting layer. The electron transport layer needs a material having high electron injection efficiency from the cathode positioned thereon and capable of efficiently transporting the injected electrons. To this end, it must be made of a material having high electron affinity and electron transfer speed and excellent stability to electrons. Examples of the electron transport material that satisfies such conditions include Al complexes of 8-hydroxyquinoline; Complexes including Alq 3 ; Organic radical compounds; Hydroxyflavone-metal complexes, and the like, but are not limited thereto.

전자수송층 위에는 음극이 위치된다. 이러한 음극은 전자수송층에 전자를 주입하는 역할을 한다. 음극으로 사용하는 재료는 양극에 사용된 재료를 이용하는 것이 가능하며, 효율적인 전자주입을 위해서는 일 함수가 낮은 금속이 보다 바람직하다. 특히 주석, 마그네슘, 인듐, 칼슘, 나트륨, 리튬, 알루미늄, 은 등의 적당한 금속, 또는 그들의 적절한 합금이 사용될 수 있다. 또한 100 ㎛ 이하 두께의 리튬플루오라이드와 알루미늄, 산화리튬과 알루미늄, 스트론튬산화물과 알루미늄 등의 2 층 구조의 전극도 사용될 수 있다.The cathode is positioned on the electron transport layer. This cathode serves to inject electrons into the electron transport layer. As the material used as the cathode, it is possible to use the material used for the anode, and a metal having a low work function is more preferable for efficient electron injection. In particular, a suitable metal such as tin, magnesium, indium, calcium, sodium, lithium, aluminum, silver, or a suitable alloy thereof can be used. In addition, an electrode having a two-layer structure such as lithium fluoride and aluminum, lithium oxide and aluminum, strontium oxide and aluminum having a thickness of 100 μm or less may also be used.

본 발명에 따른 유기전계발광소자는 사용되는 재료에 따라 전면 발광형, 후면 발광형 또는 양면 발광형일 수 있다.The organic light emitting device according to the present invention may be a top emission type, a bottom emission type or a double-sided emission type according to the material used.

한편 본 발명은, 위에서 설명한 유기전자소자를 포함하는 디스플레이장치와, 이 디스플레이장치를 구동하는 제어부를 포함하는 단말을 포함한다. 이 단말은 현재 또는 장래의 유무선 통신단말을 의미한다. 이상에서 전술한 본 발명에 따른 단말은 휴대폰 등의 이동 통신 단말기일 수 있으며, PDA, 전자사전, PMP, 리모콘, 네비게이션, 게임기, 각종 TV, 각종 컴퓨터 등 모든 단말을 포함한다.Meanwhile, the present invention includes a display device including the organic electronic device described above, and a terminal including a control unit for driving the display device. This terminal means a current or future wired or wireless communication terminal. The terminal according to the present invention described above may be a mobile communication terminal such as a mobile phone, and includes all terminals such as a PDA, an electronic dictionary, a PMP, a remote controller, a navigation device, a game machine, various TVs, various computers, and the like.

실시예Example

이하, 제조예 및 실험예를 통하여 본 발명을 보다 상세하게 설명한다. 그러나, 이하의 제조예 및 실험예는 본 발명을 예시하기 위한 것이며, 본 발명의 범위가 이들에 의하여 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Preparation Examples and Experimental Examples. However, the following Production Examples and Experimental Examples are for illustrating the present invention, and the scope of the present invention is not limited thereto.

제조예Manufacturing example

이하, 화학식 2 내지 4에 속하는 화합물들에 대한 제조예 또는 합성예를 설명한다. 다만, 화학식 2 내지 4에 속하는 화합물들의 수가 많기 때문에 화학식 2 내지 4에 속하는 화합물들 중 하나 또는 둘씩만을 예시적으로 설명한다. 본 발명이 속하는 기술분야의 통상의 지식을 가진 자, 즉 당업자라면 아래에서 설명한 제조예들를 통해 예시하지 않은 본 발명에 속하는 화합물들을 제조할 수 있다.Hereinafter, the preparation or synthesis examples of the compounds belonging to the formulas (2) to (4). However, only one or two of the compounds belonging to Formulas 2 to 4 are described as examples because of the large number of compounds belonging to Formulas 2 to 4. Those skilled in the art, that is, those skilled in the art can prepare the compounds belonging to the present invention not illustrated through the preparation examples described below.

제조예 1 : 화학식 2의 그룹에 속하는 하기의 12번 화합물의 제조 Preparation Example 1 Preparation of the Following Compound 12 of the Group of Formula 2

Figure 112009018902968-pat00006
Figure 112009018902968-pat00006

1. 제1중간체의 합성1. Synthesis of First Intermediates

Figure 112009018902968-pat00007
Figure 112009018902968-pat00007

1000 mL 2구 둥근바닥 플라스크에 1-iodo-2-nitrobenzene (102.74 mmol, 25.58 g), 2-bromophenylboronic acid (102.74 mmol, 20.63 g), tetrakistriphenylphosphine palladium(0) (3.08 mmol, 3.56 g), potassium cabonate (308.21 mmol, 42.60 g)을 넣고 용매로서 300 mL의 tetrahydrofuran(THF)와 100 mL의 물을 넣고 80 ℃에서 교반한다. 반응용액의 온도를 상온으로 내리고 다이클로로메탄으로 추출한다. 얻어진 추출액을 무수 황산마그네슘으로 건조하고 농축한다. 얻어진 혼합물을 실리카겔 관 크로마토그래피로 분리하여 제1중간체 2-bromo-2'-nitrobiphenyl을 흰색 고체로 20.00g 얻어낸다. (수율 : 70 %)In a 1000 mL two-necked round bottom flask, 1-iodo-2-nitrobenzene (102.74 mmol, 25.58 g), 2-bromophenylboronic acid (102.74 mmol, 20.63 g), tetrakistriphenylphosphine palladium (0) (3.08 mmol, 3.56 g), potassium cabonate Add (308.21 mmol, 42.60 g), add 300 mL of tetrahydrofuran (THF) and 100 mL of water as a solvent, and stir at 80 ° C. Lower the temperature of the reaction solution to room temperature and extract with dichloromethane. The obtained extract is dried over anhydrous magnesium sulfate and concentrated. The resulting mixture was separated by silica gel column chromatography to obtain 20.00 g of a first intermediate 2-bromo-2'-nitrobiphenyl as a white solid. (Yield: 70%)

1H-NMR (CDCl3) δ 8.00-8.05 (m, 2H), 7.90 (t, 1H), 7.66-7.68 (m, 3H), 7.45 (t, 1H), 7.30 (t, 1H) 1 H-NMR (CDCl 3 ) δ 8.00-8.05 (m, 2H), 7.90 (t, 1H), 7.66-7.68 (m, 3H), 7.45 (t, 1H), 7.30 (t, 1H)

2. 제2중간체의 합성2. Synthesis of Second Intermediate

Figure 112009018902968-pat00008
Figure 112009018902968-pat00008

500 mL 2구 둥근바닥 플라스크에 2-bromo-2'-nitrobiphenyl (119.86 mmol, 33.33 g), Triphenyl phosphine (287.67 mmol, 75.45 g)를 넣고 질소를 충진 하였다. 여기에 용매로서 100 mL의 o-dichlorobezene을 넣고 180℃에서 교반하였다. 반응이 끝나면 o-dichlorobezene을 단순 증류하고 얻어진 혼합물을 chloroform으로 재결정하여 흰색 고체의 표제 화합물 20.0 g을 얻었다. (수율 : 60 %) 2-bromo-2'-nitrobiphenyl (119.86 mmol, 33.33 g) and Triphenyl phosphine (287.67 mmol, 75.45 g) were added to a 500 mL two-necked round bottom flask filled with nitrogen. 100 mL of o -dichlorobezene was added thereto as a solvent and stirred at 180 ° C. After the reaction, o- dichlorobezene was simply distilled and the obtained mixture was recrystallized from chloroform to obtain 20.0 g of the title compound as a white solid. (Yield: 60%)

1H-NMR (CDCl3) δ 10.10 (s, 1H), 8.12 (d, 1H), 7.50-7.63 (m, 3H), 7.26-7.34 (m, 3H) 1 H-NMR (CDCl 3 ) δ 10.10 (s, 1H), 8.12 (d, 1H), 7.50-7.63 (m, 3H), 7.26-7.34 (m, 3H)

3. 제3중간체의 합성3. Synthesis of Third Intermediate

Figure 112009018902968-pat00009
Figure 112009018902968-pat00009

500 mL 2구 둥근바닥 플라스크에 상기 제2중간체 4-bromo-9H-carbazole (67.19 mmol, 16.53 g)을 넣고 질소를 충진 한다. 그리고 300 mL의 무수 Tetrahydrofuran(THF)를 넣고 녹인 다음 -78 ℃에서 n-Butyllithium in Hexane 2.5M (70.55 mmol, 28.22 mL)을 천천히 넣어준다. 그리고 온도를 상온으로 하고 30분 교반 뒤 다시 온도를 -78 ℃로 하고 2-bromobenzoyl chloride (67.19 mmol, 14.74 g)을 무수 Tetrahydrofuran(THF)에 묽혀 천천히 넣어 준다. 온도를 상온으로 하고 교반하고 반응이 끝나면 다이클로로메탄으로 추출하고 얻어진 추출액을 무수 황산마그네슘으로 건조하고 농축한다. 얻어진 혼합물을 실리카겔 관 크로마토그래피로 분리하여 제3중간체 (2-bromophenyl)(9H-carbazol-3-yl)methanone를 노랑색 고체로 18.02 g을 얻어낸다. (수율 : 77 %)The second intermediate 4-bromo-9H-carbazole (67.19 mmol, 16.53 g) was added to a 500 mL two-necked round bottom flask filled with nitrogen. Add 300 mL of anhydrous Tetrahydrofuran (THF), dissolve, and slowly add n-Butyllithium in Hexane 2.5M (70.55 mmol, 28.22 mL) at -78 ° C. The temperature was allowed to stand at room temperature, followed by stirring for 30 minutes. The temperature was then set to -78 ° C, and 2-bromobenzoyl chloride (67.19 mmol, 14.74 g) was diluted in anhydrous Tetrahydrofuran (THF) and slowly added. The temperature is brought to room temperature and stirred. After completion of the reaction, the mixture is extracted with dichloromethane and the extract is dried over anhydrous magnesium sulfate and concentrated. The resulting mixture was separated by silica gel column chromatography to give 18.02 g of a third intermediate (2-bromophenyl) (9H-carbazol-3-yl) methanone as a yellow solid. (Yield: 77%)

1H-NMR (CDCl3) δ 10.10 (s, 1H), 8.74 (s, 1H) 8.12 (d, 1H), 7.98 (d, 1H), 7.50-7.73 (m, 7H), 7.29 (t, 1H) 1 H-NMR (CDCl 3 ) δ 10.10 (s, 1H), 8.74 (s, 1H) 8.12 (d, 1H), 7.98 (d, 1H), 7.50-7.73 (m, 7H), 7.29 (t, 1H )

4. 제4중간체의 합성4. Synthesis of the fourth intermediate

Figure 112009018902968-pat00010
Figure 112009018902968-pat00010

1000 mL 2구 둥근바닥 플라스크에 상기 제3중간체 (2-bromophenyl)(9H-carbazol-4-yl)methanone (85.66 mmol, 27.77 g), Pd(OAc)2 (0.86 mmol, 0.19 g)를 넣고 질소를 충진 한다. 여기에 용매로서 500 mL의 Dimethyformamide를 넣고 P(o-tol)3 (1.71 mmol, 0.52 g)를 넣은 다음 90 ℃에서 교반한다. 반응이 끝나면 반응용액의 온도를 상온으로 내리고 에탄올을 가하여 침전물을 필터한다. 얻어진 혼합물을 실리카겔 관 크로마토그래피(용리액 - 다이클로로메탄:n-헥산 = 3:7)로 분리하여 제4중간체 indeno[1,2-c]carbazol-12(5H)-one를 흰색 고체로 15.0 g을 얻어낸 다. (수율 : 50 %)Into a 1000 mL two-necked round bottom flask, put the third intermediate (2-bromophenyl) (9H-carbazol-4-yl) methanone (85.66 mmol, 27.77 g) and Pd (OAc) 2 (0.86 mmol, 0.19 g) To fill. Add 500 mL of Dimethyformamide as a solvent, add P (o-tol) 3 (1.71 mmol, 0.52 g), and stir at 90 ° C. After the reaction, the reaction solution is cooled to room temperature and ethanol is added to filter the precipitate. The resulting mixture was separated by silica gel column chromatography (eluent-dichloromethane: n-hexane = 3: 7) to give 15.0 g of the fourth intermediate indeno [1,2-c] carbazol-12 (5H) -one as a white solid. To get. (Yield: 50%)

1H-NMR (CDCl3) δ 10.10(s, 1H), 8.44?7.29 (m, 9H) 1 H-NMR (CDCl 3 ) δ 10.10 (s, 1H), 8.44-7.29 (m, 9H)

5. 제5중간체의 합성5. Synthesis of Fifth Intermediates

Figure 112009018902968-pat00011
Figure 112009018902968-pat00011

500 mL 2구 둥근바닥 플라스크에 상기 제4중간체 indeno[1,2-c]carbazol-12(5H)-one (68.57 mmol, 18.47 g), bromobenzene (68.57 mmol, 10.77 g), Pd2(dba)3 (2.06 mmol, 1.88 g), 소디움터트부톡사이드 (205.72 mmol, 19.77 g)를 넣고 질소를 충진 한다. 여기에 용매로서 250 mL의 톨루엔을 넣고 트리터트부틸포스핀 (6.86 mmol, 1.39 g)을 넣은 다음 110 ℃에서 3시간 동안 교반한다. 반응용액의 온도를 상온으로 내리고 다이클로로메탄으로 추출한다. 얻어진 추출액을 무수 황산마그네슘으로 건조하고 분별증류하여 용매를 제거한다. 얻어진 혼합물을 실리카겔 관 크로마토그래피(용리액 - 다이클로로메탄:n-헥산 = 4:6)로 분리하여 제5중간체 5-phenylindeno[1,2-c]carbazol-12(5H)-one를 흰색 고체로 18.0 g을 얻어낸다. (수율 : 76 %)In a 500 mL two-necked round bottom flask, the fourth intermediate indeno [1,2-c] carbazol-12 (5H) -one (68.57 mmol, 18.47 g), bromobenzene (68.57 mmol, 10.77 g), Pd2 (dba) 3 (2.06 mmol, 1.88 g) and sodium tert-butoxide (205.72 mmol, 19.77 g) are added and charged with nitrogen. 250 mL of toluene was added thereto as a solvent, tritertbutylphosphine (6.86 mmol, 1.39 g) was added thereto, followed by stirring at 110 ° C. for 3 hours. Lower the temperature of the reaction solution to room temperature and extract with dichloromethane. The obtained extract is dried over anhydrous magnesium sulfate and fractional distillation to remove the solvent. The resulting mixture was separated by silica gel column chromatography (eluent-dichloromethane: n-hexane = 4: 6) to give the fifth intermediate 5-phenylindeno [1,2-c] carbazol-12 (5H) -one as a white solid. 18.0 g is obtained. (Yield: 76%)

1H-NMR (CDCl3) δ 8.55-7.25 (m, 15H) 1 H-NMR (CDCl 3 ) δ 8.55-7.25 (m, 15H)

6. 제6중간체의 합성6. Synthesis of Sixth Intermediate

Figure 112009018902968-pat00012
Figure 112009018902968-pat00012

500 mL 2구 둥근바닥 플라스크에 상기 제5중간체 5-phenylindeno[1,2-c]carbazol-12(5H)-one (60.28 mmol, 20.82 g)을 넣고 질소를 충진 한다. 그리고 300 mL의 무수 diethyl ether를 넣고 녹인 다음 -78 ℃에서 Methylmagnesium bromide 3M (63.03 mmol, 25.32 mL)을 천천히 넣어준다. 그리고 천천히 온도를 상온으로 하고 교반하고 반응이 끝나면 다이클로로메탄으로 추출하고 얻어진 추출액을 무수 황산마그네슘으로 건조하고 농축한다. 얻어진 혼합물을 실리카겔 관 크로마토그래피로 분리하여 제6중간체 12,12-dimethyl-5-phenyl-5,12-dihydroindeno[1,2-c]carbazole를 노랑색 고체로 19.0 g을 얻어낸다. (수율 : 90 %)The fifth intermediate 5-phenylindeno [1,2-c] carbazol-12 (5H) -one (60.28 mmol, 20.82 g) was added to a 500 mL two neck round bottom flask, and charged with nitrogen. Then, add 300 mL of anhydrous diethyl ether, dissolve it, and slowly add Methylmagnesium bromide 3M (63.03 mmol, 25.32 mL) at -78 ° C. Then, slowly bring the temperature to room temperature and stir. After the reaction is completed, the mixture is extracted with dichloromethane, and the extract is dried over anhydrous magnesium sulfate and concentrated. The resulting mixture was separated by silica gel column chromatography to give 19.0 g of a sixth intermediate 12,12-dimethyl-5-phenyl-5,12-dihydroindeno [1,2-c] carbazole as a yellow solid. (Yield: 90%)

1H-NMR (CDCl3) δ 8.09-7.24 (m, 15H), 1.72 (s, 6H) 1 H-NMR (CDCl 3 ) δ 8.09-7.24 (m, 15H), 1.72 (s, 6H)

7. 제7중간체의 합성7. Synthesis of Intermediate

Figure 112009018902968-pat00013
Figure 112009018902968-pat00013

500 mL 2구 둥근바닥 플라스크에 상기 제6중간체 12,12-dimethyl-5-phenyl-5,12-dihydroindeno[1,2-c]carbazole(47.26 mmol, 16.99 g)을 넣고 N-bromosuccinimide(96.88 mmol, 9.80 g)을 넣고 300 mL의 dichloromethane을 넣고 상온에서 교반한다. 반응이 끝나면 다이클로로메탄으로 묽혀 추출하고 얻어진 추출액을 무수 황산마그네슘으로 건조하고 농축한다. 얻어진 혼합물을 dichloromethane에 녹여 메탄올에 재결정하여 필터함으로써 제7중간체 2,10-dibromo-12,12-dimethyl-5-phenyl-5,12-dihydroindeno[1,2-c]carbazole를 노랑색 고체로 22.0 g을 얻어낸다. (수율 : 90 %)In a 500 mL two-necked round bottom flask, 6th intermediate 12,12-dimethyl-5-phenyl-5,12-dihydroindeno [1,2-c] carbazole (47.26 mmol, 16.99 g) was added and N-bromosuccinimide (96.88 mmol). , 9.80 g), add 300 mL of dichloromethane and stir at room temperature. After the reaction, the mixture was diluted with dichloromethane and extracted. The extract was dried over anhydrous magnesium sulfate and concentrated. The resulting mixture was dissolved in dichloromethane, recrystallized from methanol, and filtered to obtain 22.0 g of 7th intermediate 2,10-dibromo-12,12-dimethyl-5-phenyl-5,12-dihydroindeno [1,2-c] carbazole as a yellow solid. To get. (Yield: 90%)

1H-NMR (CDCl3) δ 7.98-7.25 (m, 13H), 1.72 (s, 6H) 1 H-NMR (CDCl 3 ) δ 7.98-7.25 (m, 13H), 1.72 (s, 6H)

8. 제8중간체의 합성8. Synthesis of 8th Intermediate

Figure 112009018902968-pat00014
Figure 112009018902968-pat00014

500 mL 2구 둥근바닥 플라스크에 상기 제7중간체 2,10-dibromo-12,12-dimethyl-5-phenyl-5,12-dihydroindeno[1,2-c]carbazole (59.91 mmol, 30.99 g)을 넣고 질소를 충진 한다. 그리고 300 mL의 무수 Tetrahydrofuran(THF)를 넣고 녹인 다음 -78 ℃에서 n-Butyllithium in Hexane 2.5M (62.91 mmol, 25.16 mL)을 천천히 넣어준다. 그리고 온도를 상온으로 하고 30분 교반 뒤 다시 온도를 -78 ℃로 하고 Chlorotrimethylsilane (89.87 mmol, 9.76 g)을 천천히 넣어 준다. 온도를 상온으로 하고 교반하고 반응이 끝나면 다이클로로메탄으로 추출하고 얻어진 추출액을 무수 황산마그네슘으로 건조하고 농축한다. 얻어진 혼합물을 재결정하여 제8중간체 10-bromo-12,12-dimethyl-5-phenyl-2-(trimethylsilyl)-5,12-dihydroindeno[1,2-c]carbazole을 26.0 g을 얻어낸다. (수율 : 80 %)In a 500 mL two-necked round bottom flask, 7th intermediate 2,10-dibromo-12,12-dimethyl-5-phenyl-5,12-dihydroindeno [1,2-c] carbazole (59.91 mmol, 30.99 g) was added thereto. Fill with nitrogen. Add 300 mL of anhydrous Tetrahydrofuran (THF), dissolve it, and slowly add n-Butyllithium in Hexane 2.5M (62.91 mmol, 25.16 mL) at -78 ° C. The temperature was allowed to stand at room temperature, followed by stirring for 30 minutes, and then the temperature was set at -78 ° C. Chlorotrimethylsilane (89.87 mmol, 9.76 g) was slowly added thereto. The temperature is brought to room temperature and stirred. After completion of the reaction, the mixture is extracted with dichloromethane and the extract is dried over anhydrous magnesium sulfate and concentrated. The obtained mixture was recrystallized to obtain 26.0 g of the eighth intermediate 10-bromo-12,12-dimethyl-5-phenyl-2- (trimethylsilyl) -5,12-dihydroindeno [1,2-c] carbazole. (Yield: 80%)

1H-NMR (CDCl3) δ 7.98-7.30 (m, 13H), 1.72 (S, 6H), 0.25 (S, 9H) 1 H-NMR (CDCl 3 ) δ 7.98-7.30 (m, 13H), 1.72 (S, 6H), 0.25 (S, 9H)

8. 12번 화합물의 합성8. Synthesis of Compound 12

Figure 112009018902968-pat00015
Figure 112009018902968-pat00015

1000 mL 2구 둥근바닥 플라스크에 상기 중간체 10-bromo-12,12-dimethyl-5-phenyl-2-(trimethylsilyl)-5,12-dihydroindeno[1,2-c]carbazole (38.43 mmol, 19.62 g), dibiphenyl-4-ylamine (38.43 mmol, 12.35 g), Pd2(dba)3 (1.15 mmol, 1.06 g), 소디움터트부톡사이드 (115.28 mmol, 11.08 g)를 넣고 질소를 충진한다. 여기에 용매로서 500 mL의 톨루엔을 넣고 트리터트부틸포스핀 (3.84 mmol, 0.78 g)을 넣은 다음 90 ℃에서 2시간 동안 교반한다. 반응용액의 온도를 상온으로 내리고 2M-HCl 100 mL 30분 교반 후 다이클로로메탄으로 추출한다. 얻어진 추출액을 무수 황산마그네슘으로 건조하고 분별증류하여 용매를 제거한다. 얻어진 혼합물을 실리카겔 관 크로마토그래피 분리하여 12번 화합물 24.0 g을 얻어낸다. (수율 : 92 %)Intermediate 10-bromo-12,12-dimethyl-5-phenyl-2- (trimethylsilyl) -5,12-dihydroindeno [1,2-c] carbazole (38.43 mmol, 19.62 g) in a 1000 mL two-necked round bottom flask , dibiphenyl-4-ylamine (38.43 mmol, 12.35 g), Pd2 (dba) 3 (1.15 mmol, 1.06 g), sodium tert-butoxide (115.28 mmol, 11.08 g) were added and filled with nitrogen. To this was added 500 mL of toluene as a solvent, tritertbutylphosphine (3.84 mmol, 0.78 g) was added, followed by stirring at 90 ° C for 2 hours. Lower the temperature of the reaction solution to room temperature and stir 2 mL 100 mL of 2M-HCl and extract with dichloromethane. The obtained extract is dried over anhydrous magnesium sulfate and fractional distillation to remove the solvent. The resulting mixture was separated by silica gel column chromatography to give 24.0 g of compound 12. (Yield: 92%)

1H-NMR (CDCl3) δ 7.94-7.28 (m, 26H), 6.81-6.69 (m, 5H), 1.72 (s, 6H) 1 H-NMR (CDCl 3 ) δ 7.94-7.28 (m, 26H), 6.81-6.69 (m, 5H), 1.72 (s, 6H)

제조예 2 : 화학식 3의 그룹에 속하는 하기의 15번 화합물의 제조 Preparation Example 2 Preparation of the Following Compound 15 belonging to the Group of Formula 3

Figure 112009018902968-pat00016
Figure 112009018902968-pat00016

1. 15번 화합물의 합성1.Synthesis of Compound 15

Figure 112009018902968-pat00017
Figure 112009018902968-pat00017

15번 화합물의 화합물을 합성하는 과정에 있어서, 중간체를 합성하는 과정은 앞서 설명한 12번 화합물을 참조한다.In the process of synthesizing the compound of compound 15, the process of synthesizing the intermediate refers to compound 12 described above.

1000 mL 2구 둥근바닥 플라스크에 10-bromo-12,12-dimethyl-5-phenyl-2-(trimethylsilyl)-5,12-dihydroindeno[1,2-c]carbazole (62.23 mmol, 31.77 g), N-(biphenyl-4-yl)-9,9-dimethyl-9H-fluoren-2-amine (62.23 mmol, 22.49 g), Pd2(dba)3 (1.87 mmol, 1.71 g), 소디움터트부톡사이드 (186.68 mmol, 17.94 g)를 넣고 질소를 충진한다. 여기에 용매로서 500 mL의 톨루엔을 넣고 트리터트부틸포스핀 (6.22 mmol, 1.26 g)을 넣은 다음 90 ℃에서 2시간 동안 교반한다. 반응용액의 온도를 상온으로 내리고 2M-HCl 100 mL 30분 교반 후 다이클로로메탄으로 추출한다. 얻어진 추출액을 무수 황산마그네슘으로 건조하고 분별증류하여 용매를 제거한다. 얻어진 혼합물을 실리카겔 관 크로마토그래피 분리하여 15번 화합물로 흰색 고체 34.0 g을 얻어낸다. (수율 : 76 %)10-bromo-12,12-dimethyl-5-phenyl-2- (trimethylsilyl) -5,12-dihydroindeno [1,2-c] carbazole (62.23 mmol, 31.77 g), N in a 1000 mL two-necked round bottom flask -(biphenyl-4-yl) -9,9-dimethyl-9H-fluoren-2-amine (62.23 mmol, 22.49 g), Pd2 (dba) 3 (1.87 mmol, 1.71 g), sodium tertbutoxide (186.68 mmol , 17.94 g) is charged with nitrogen. To this was added 500 mL of toluene as a solvent, tritertbutylphosphine (6.22 mmol, 1.26 g) was added, followed by stirring at 90 ° C. for 2 hours. Lower the temperature of the reaction solution to room temperature and stir 2 mL 100 mL of 2M-HCl and extract with dichloromethane. The obtained extract is dried over anhydrous magnesium sulfate and fractional distillation to remove the solvent. The resulting mixture was separated by silica gel column chromatography to give 34.0 g of a white solid as compound 15. (Yield: 76%)

1H-NMR (CDCl3) δ 7.94-7.28 (m, 19H), 6.58-6.75 (m, 5H), 1.72 (s, 12H) 1 H-NMR (CDCl 3 ) δ 7.94-7.28 (m, 19H), 6.58-6.75 (m, 5H), 1.72 (s, 12H)

제조예 3 : 화학식 4의 그룹에 속하는 하기의 42번 화합물의 제조 Preparation Example 3 Preparation of the Following Compound 42 belonging to the Group of Formula 4

Figure 112009018902968-pat00018
Figure 112009018902968-pat00018

1. 제1중간체의 합성1. Synthesis of First Intermediates

Figure 112009018902968-pat00019
Figure 112009018902968-pat00019

42번 화합물의 중간체 합성에 있어서, 상기 제1중간체를 합성하기 위한 과정의 일부는 앞서 설명한 12번 화합물을 참조한다.In the synthesis of the intermediate of compound 42, part of the procedure for synthesizing the first intermediate refers to compound 12 described above.

1000 mL 2구 둥근바닥 플라스크에 10-bromo-12,12-dimethyl-5-phenyl-2-(trimethylsilyl)-5,12-dihydroindeno[1,2-c]carbazole (45.70 mmol, 23.33 g), N1,N1,N4-triphenylbenzene-1,4-diamine (45.70 mmol, 15.37 g), Pd2(dba)3 (1.37 mmol, 1.26 g), 소디움터트부톡사이드 (137.09 mmol, 13.18 g)를 넣고 질소를 충진 한다. 여기에 용매로서 500 mL의 톨루엔을 넣고 트리터트부틸포스핀 (4.57 mmol, 0.92 g)을 넣은 다음 90 ℃에서 2시간 동안 교반한다. 반응용액의 온도를 상온으로 내리고 2M-HCl 100 mL 30분 교반 후 다이클로로메탄으로 추출한다. 얻어진 추출액을 무수 황산마그네슘으로 건조하고 분별증류하여 용매를 제거한다. 얻어진 혼합물을 실리카겔 관 크로마토그래피 분리하여 제1중간체 N1-(12,12-dimethyl-5-phenyl-5,12-dihydroindeno[1,2-c]carbazol-10-yl)-N1,N4,N4-triphenylbenzene-1,4-diamine를 흰색 고체로 26 g을 얻어낸다. (수율 : 82 %)10-bromo-12,12-dimethyl-5-phenyl-2- (trimethylsilyl) -5,12-dihydroindeno [1,2-c] carbazole (45.70 mmol, 23.33 g), N1 in a 1000 mL two-necked round bottom flask , N1, N4-triphenylbenzene-1,4-diamine (45.70 mmol, 15.37 g), Pd2 (dba) 3 (1.37 mmol, 1.26 g), sodium tert-butoxide (137.09 mmol, 13.18 g) were added and filled with nitrogen. . To this was added 500 mL of toluene as a solvent, tritertbutylphosphine (4.57 mmol, 0.92 g) was added, followed by stirring at 90 ° C. for 2 hours. Lower the temperature of the reaction solution to room temperature and stir 2 mL 100 mL of 2M-HCl and extract with dichloromethane. The obtained extract is dried over anhydrous magnesium sulfate and fractional distillation to remove the solvent. The resulting mixture was subjected to silica gel column chromatography to separate the first intermediate N1- (12,12-dimethyl-5-phenyl-5,12-dihydroindeno [1,2-c] carbazol-10-yl) -N1, N4, N4- 26 g of triphenylbenzene-1,4-diamine is obtained as a white solid. (Yield: 82%)

1H-NMR (CDCl3) δ 8.55 (d, 1H), 7.84-7.20 (m, 17H), 6.81-6.38 (m, 13H), 1.72 (s, 6H) 1 H-NMR (CDCl 3 ) δ 8.55 (d, 1H), 7.84-7.20 (m, 17H), 6.81-6.38 (m, 13H), 1.72 (s, 6H)

2. 제2중간체의 합성2. Synthesis of Second Intermediate

Figure 112009018902968-pat00020
Figure 112009018902968-pat00020

500 mL 2구 둥근바닥 플라스크에 상기 제1중간체 N1-(12,12-dimethyl-5-phenyl-5,12-dihydroindeno[1,2-c]carbazol-10-yl)-N1,N4,N4-triphenylbenzene-1,4-diamine(37.57 mmol, 13.50 g)을 넣고 N-bromosuccinimide(39.45 mmol, 3.99 g)을 넣고 300 mL의 dichloromethane을 넣고 상온에서 교반한다. 반응이 끝나면 다이클로로메탄으로 묽혀 추출하고 얻어진 추출액을 무수 황산마그네슘으로 건조하고 농축한다. 얻어진 혼합물을 재결정하여 필터함으로써 제2중간체 N1-(2-bromo-12,12-dimethyl-5-phenyl-5,12-dihydroindeno[1,2-c]carbazol-10-yl)-N1,N4,N4-triphenylbenzene-1,4-diamine를 흰색 고체로 27.0 g을 얻어낸다. (수율 : 93 %)The first intermediate N1- (12,12-dimethyl-5-phenyl-5,12-dihydroindeno [1,2-c] carbazol-10-yl) -N1, N4, N4- in a 500 mL two-necked round bottom flask Add triphenylbenzene-1,4-diamine (37.57 mmol, 13.50 g), add N-bromosuccinimide (39.45 mmol, 3.99 g), add 300 mL of dichloromethane, and stir at room temperature. After the reaction, the mixture was diluted with dichloromethane and extracted. The extract was dried over anhydrous magnesium sulfate and concentrated. The obtained mixture was recrystallized and filtered to obtain the second intermediate N1- (2-bromo-12,12-dimethyl-5-phenyl-5,12-dihydroindeno [1,2-c] carbazol-10-yl) -N1, N4, 27.0 g of N4-triphenylbenzene-1,4-diamine is obtained as a white solid. (Yield 93%)

1H-NMR (CDCl3) δ 7.84-7.20 (m, 17H), 6.81-6.38 (m, 13H), 1.72 (s, 6H) 1 H-NMR (CDCl 3 ) δ 7.84-7.20 (m, 17H), 6.81-6.38 (m, 13H), 1.72 (s, 6H)

3. 42번 화합물의 합성3. Synthesis of Compound 42

Figure 112009018902968-pat00021
Figure 112009018902968-pat00021

500 mL 2구 둥근바닥 플라스크에 상기 제2중간체 N1-(2-bromo-12,12-dimethyl-5-phenyl-5,12-dihydroindeno[1,2-c]carbazol-10-yl)-N1,N4,N4-triphenylbenzene-1,4-diamine (22.43 mmol, 17.34 g), diphenylamine (22.43 mmol, 3.8 g) Pd2(dba)3 (0.67 mmol, 0.62 g), 소디움터트부톡사이드 (67.30 mmol, 6.47 g)를 넣고 질소를 충진한다. 여기에 용매로서 250 mL의 톨루엔을 넣고 트리터트부틸포스핀 (2.24 mmol, 0.42 g)을 넣은 다음 90 ℃에서 2시간 동안 교반한다. 반응용액의 온도를 상온으로 내리고 다이클로로메탄으로 추출하였다. 얻어진 추출액을 무수 황산마그네슘으로 건조하고 분별증류하여 용매를 제거한다. 얻어진 혼합물을 실리카겔 관 크로마토그래피 분리하여 42번 화합물을 흰색 고체로 17 g을 얻어낸다. (수율 : 88 %)In a 500 mL two-necked round bottom flask, the second intermediate N1- (2-bromo-12,12-dimethyl-5-phenyl-5,12-dihydroindeno [1,2-c] carbazol-10-yl) -N1, N4, N4-triphenylbenzene-1,4-diamine (22.43 mmol, 17.34 g), diphenylamine (22.43 mmol, 3.8 g) Pd2 (dba) 3 (0.67 mmol, 0.62 g), sodium tertbutoxide (67.30 mmol, 6.47 g ) And fill with nitrogen. 250 mL of toluene was added thereto as a solvent, tritertbutylphosphine (2.24 mmol, 0.42 g) was added thereto, followed by stirring at 90 ° C for 2 hours. The reaction solution was cooled to room temperature and extracted with dichloromethane. The obtained extract is dried over anhydrous magnesium sulfate and fractional distillation to remove the solvent. The resulting mixture was separated by silica gel column chromatography to give 17 g of compound 42 as a white solid. (Yield: 88%)

1H-NMR (CDCl3) δ 7.79-7.20 (m, 19H), 6.81-6.38 (m, 21H), 5.93 (d, 1H), 1.72 (s, 6H) 1 H-NMR (CDCl 3 ) δ 7.79-7.20 (m, 19H), 6.81-6.38 (m, 21H), 5.93 (d, 1H), 1.72 (s, 6H)

제조예 4 : 화학식 4의 그룹에 속하는 하기의 43번 화합물의 제조 Preparation Example 4 Preparation of the Following Compound 43 belonging to the Group of Formula 4

Figure 112009018902968-pat00022
Figure 112009018902968-pat00022

1. 제1중간체의 합성1. Synthesis of First Intermediates

Figure 112009018902968-pat00023
Figure 112009018902968-pat00023

43번 화합물의 중간체 합성에 있어서, 상기 제1중간체를 합성하기 위한 과정에 이르는 단계는 앞서 설명한 12번 화합물을 참조한다.In the synthesis of the intermediate of the compound 43, the steps leading to the process for synthesizing the first intermediate, refer to the compound 12 described above.

1000 mL 2구 둥근바닥 플라스크에 10-bromo-12,12-dimethyl-5-phenyl-2-(trimethylsilyl)-5,12-dihydroindeno[1,2-c]carbazole (40.81 mmol, 20.84 g), N,9-diphenyl-9H-carbazol-3-amine (40.81 mmol, 13.73 g), Pd2(dba)3 (1.22 mmol, 1.12 g), 소디움터트부톡사이드 (122.43 mmol, 11.77 g)를 넣고 질소를 충진한다. 여기에 용매로서 500 mL의 톨루엔을 넣고 트리터트부틸포스핀 (4.08 mmol, 0.83 g)을 넣은 다음 90 ℃에서 2시간 동안 교반한다. 반응용액의 온도를 상온으로 내리고 2M-HCl 100 mL 30분 교반 후 다이클로로메탄으로 추출한다. 얻어진 추출액을 무수 황산마그네슘으로 건조하고 분별증류하여 용매를 제거한다. 얻어진 혼합물을 실리카겔 관 크로마토그래피 분리하여 제1중간체 12,12-dimethyl-N,5-diphenyl-N-(9-phenyl-9H-carbazol-3-yl)-5,12-dihydroindeno[1,2-c]carbazol-10-amine를 흰색 고체로 24 g을 얻어낸다. (수율 : 85 %)10-bromo-12,12-dimethyl-5-phenyl-2- (trimethylsilyl) -5,12-dihydroindeno [1,2-c] carbazole (40.81 mmol, 20.84 g), N in a 1000 mL two-necked round bottom flask , 9-diphenyl-9H-carbazol-3-amine (40.81 mmol, 13.73 g), Pd2 (dba) 3 (1.22 mmol, 1.12 g), sodium tert-butoxide (122.43 mmol, 11.77 g) were added and charged with nitrogen. . To this was added 500 mL of toluene as a solvent, tritertbutylphosphine (4.08 mmol, 0.83 g) was added, followed by stirring at 90 ° C. for 2 hours. Lower the temperature of the reaction solution to room temperature and stir 2 mL 100 mL of 2M-HCl and extract with dichloromethane. The obtained extract is dried over anhydrous magnesium sulfate and fractional distillation to remove the solvent. The resulting mixture was subjected to silica gel column chromatography to separate the first intermediate 12,12-dimethyl-N, 5-diphenyl-N- (9-phenyl-9H-carbazol-3-yl) -5,12-dihydroindeno [1,2- c) 24 g of carbazol-10-amine as a white solid. (Yield: 85%)

1H-NMR (CDCl3) δ 8.55 (d, 1H), 7.84-7.20 (m, 17H), 6.81-6.38 (m, 11H), 1.72 (s, 6H) 1 H-NMR (CDCl 3 ) δ 8.55 (d, 1H), 7.84-7.20 (m, 17H), 6.81-6.38 (m, 11H), 1.72 (s, 6H)

2. 제2중간체의 합성2. Synthesis of Second Intermediate

Figure 112009018902968-pat00024
Figure 112009018902968-pat00024

500 mL 2구 둥근바닥 플라스크에 상기 제1중간체 12,12-dimethyl-N,5-diphenyl-N-(9-phenyl-9H-carbazol-3-yl)-5,12-dihydroindeno[1,2-c]carbazol-10-amine (30.05 mmol, 20.79 g)을 넣고 N-bromosuccinimide (31.55 mmol, 3.19 g)을 넣고 300 mL의 dichloromethane을 넣고 상온에서 교반한다. 반응이 끝나면 다이클로로메탄으로 묽혀 추출하고 얻어진 추출액을 무수 황산마그네슘으로 건조하고 농축한다. 얻어진 혼합물을 재결정하여 필터함으로써 제2중간체 2-bromo-12,12- dimethyl-N,5-diphenyl-N-(9-phenyl-9H-carbazol-3-yl)-5,12-dihydroindeno[1,2-c]carbazol-10-amine를 흰색 고체로 22.0 g을 얻어낸다. (수율 : 95 %)In a 500 mL two-necked round bottom flask, the first intermediate 12,12-dimethyl-N, 5-diphenyl-N- (9-phenyl-9H-carbazol-3-yl) -5,12-dihydroindeno [1,2- c] carbazol-10-amine (30.05 mmol, 20.79 g) was added, N-bromosuccinimide (31.55 mmol, 3.19 g) was added, 300 mL of dichloromethane was added thereto, and the mixture was stirred at room temperature. After the reaction, the mixture was diluted with dichloromethane and extracted. The extract was dried over anhydrous magnesium sulfate and concentrated. The obtained mixture was recrystallized and filtered to obtain the second intermediate 2-bromo-12,12-dimethyl-N, 5-diphenyl-N- (9-phenyl-9H-carbazol-3-yl) -5,12-dihydroindeno [1,2]. 22.0 g of 2-c] carbazol-10-amine is obtained as a white solid. (Yield 95%)

1H-NMR (CDCl3) δ 7.84-7.20 (m, 17H), 6.81-6.38 (m, 11H), 1.72 (s, 6H) 1 H-NMR (CDCl 3 ) δ 7.84-7.20 (m, 17H), 6.81-6.38 (m, 11H), 1.72 (s, 6H)

3. 43번 화합물의 합성3. Synthesis of Compound 43

Figure 112009018902968-pat00025
Figure 112009018902968-pat00025

500 mL 2구 둥근바닥 플라스크에 상기 제2중간체 2-bromo-12,12-dimethyl-N,5-diphenyl-N-(9-phenyl-9H-carbazol-3-yl)-5,12-dihydroindeno[1,2-c]carbazol-10-amine (17.71 mmol, 13.65 g), diphenylamine (17.71 mmol, 3.00 g) Pd2(dba)3 (0.53 mmol, 0.49 g), 소디움터트부톡사이드 (53.14 mmol, 5.11 g)를 넣고 질소를 충진한다. 여기에 용매로서 250 mL의 톨루엔을 넣고 트리터트부틸포스핀 (1.77 mmol, 0.36 g)을 넣은 다음 90 ℃에서 2시간 동안 교반한다. 반응용액의 온도를 상온으로 내리고 다이클로로메탄으로 추출하였다. 얻어진 추출액을 무수 황산마그네슘으로 건조하고 분별증류하여 용매를 제거한다. 얻어진 혼합물을 실리카겔 관 크로마토그래피 분리하여 43번 화합물을 흰색 고체로 14 g을 얻어낸다. (수율 : 92 %)In a 500 mL two-necked round bottom flask, the second intermediate 2-bromo-12,12-dimethyl-N, 5-diphenyl-N- (9-phenyl-9H-carbazol-3-yl) -5,12-dihydroindeno [ 1,2-c] carbazol-10-amine (17.71 mmol, 13.65 g), diphenylamine (17.71 mmol, 3.00 g) Pd2 (dba) 3 (0.53 mmol, 0.49 g), sodium tertbutoxide (53.14 mmol, 5.11 g ) And fill with nitrogen. 250 mL of toluene was added thereto as a solvent, tritertbutylphosphine (1.77 mmol, 0.36 g) was added thereto, followed by stirring at 90 ° C. for 2 hours. The reaction solution was cooled to room temperature and extracted with dichloromethane. The obtained extract is dried over anhydrous magnesium sulfate and fractional distillation to remove the solvent. The resulting mixture was separated by silica gel column chromatography to yield 14 g of compound 43 as a white solid. (Yield: 92%)

1H-NMR (CDCl3) δ 7.79-7.20 (m, 19H), 6.81-6.38 (m, 19H), 5.93 (d, 1H), 1.72 (s, 6H) 1 H-NMR (CDCl 3 ) δ 7.79-7.20 (m, 19H), 6.81-6.38 (m, 19H), 5.93 (d, 1H), 1.72 (s, 6H)

실험예Experimental Example

본 발명의 화합물 42, 43과 비교를 위해 정공주입층으로 2-TNATA를 사용한 유기전계발광소자의 물성을 측정하여 비교하였다.For comparison with compounds 42 and 43 of the present invention, the physical properties of organic light emitting diodes using 2-TNATA as the hole injection layer were measured and compared.

4,4’,4”-Tris[2-naphthyl(phenyl)amino]-triphenylamine (2-TNATA)를 정공주입층 물질로 사용하여 통상적인 방법에 따라 유기전계발광소자를 제작하였다.4,4 ', 4 ”-Tris [2-naphthyl (phenyl) amino] -triphenylamine (2-TNATA) was used as a hole injection layer material, and an organic light emitting diode was manufactured according to a conventional method.

먼저, 유리 기판에 형성된 ITO층(양극) 위에 600 Å 두께의 정공주입층(정공주입층 물질 : 2-TNATA), 300 Å 두께의 정공수송층(정공수송층 물질 : NPB), 450 Å 두께의 BD-052X(Idemitsu사)가 7% 도핑된 발광층(이때, BD-052X는 청색 형광 도펀트이고, 발광 호스트 물질로는 9,10-디(나프탈렌-2-일)안트라센(ADN)을 사용하였다), 250 Å 두께의 전자수송층 (전자수송층 물질: 트리스(8-퀴놀리놀라토)알루미늄(Alq3)), 10 Å 두께의 전자주입층 (전자주입층 물질: LiF) 및 1500 Å 두께의 알루미늄음극을 순차적으로 증착시켜 유기전계발광소자를 제작하였다.First, a 600 Å hole injection layer (hole injection layer material: 2-TNATA), a 300 Å hole transport layer (hole transport layer material: NPB), and 450 Å thickness BD- on the ITO layer (anode) formed on the glass substrate. Light-emitting layer doped with 052X (Idemitsu Co., Ltd.) 7% (where BD-052X is a blue fluorescent dopant and 9,10-di (naphthalen-2-yl) anthracene (ADN) was used as a light emitting host material), 250 전자 thick electron transport layer (electron transport layer material: tris (8-quinolinolato) aluminum (Alq3)), 10 Å thick electron injection layer (electron injection layer material: LiF) and 1500 Å thick aluminum cathode The deposition produced an organic light emitting display device.

이렇게 제작된 유기전계발광소자의 구동전압, 전류밀도, 효율, 색좌표는 각각 6.95V, 14.31mA/cm2, 5.21cd/A, (0.145, 0.143)로 측정되었다.The driving voltage, current density, efficiency, and color coordinates of the organic light emitting diode fabricated as described above were measured to be 6.95V, 14.31mA / cm 2 , 5.21cd / A, and (0.145, 0.143), respectively.

실험예 1(본 발명의 화합물 42를 정공주입층으로 사용한 유기전계발광소자의 물성 측정) Experimental Example 1 (Measurement of Physical Properties of Organic Electroluminescent Device Using Compound 42 of the Present Invention as Hole Injection Layer)

화합물 42를 정공주입층 물질로 사용하여 통상적인 방법에 따라 유기전계발광소자를 제작하였다.Using the compound 42 as the hole injection layer material, an organic light emitting display device was manufactured according to a conventional method.

먼저, 유리 기판에 형성된 ITO층(양극) 위에 600 Å 두께의 정공주입층(정공주입층 물질 : 화합물 70), 300Å 두께의 정공수송층(정공수송층 물질 : NPB), 450 Å 두께의 BD-052X(Idemitsu사)가 7% 도핑된 발광층(이때, BD-052X는 청색 형광 도펀트이고, 발광 호스트 물질로는 9,10-디(나프탈렌-2-일)안트라센(ADN)을 사용하였다), 250 Å 두께의 전자수송층 (전자수송층 물질: 트리스(8-퀴놀리놀라토)알루미늄(Alq3)), 10 Å 두께의 전자주입층 (전자주입층 물질: LiF) 및 1500 Å 두께의 알루미늄 음극을 순차적으로 증착시켜 유기전계발광소자를 제작하였다.First, a 600 Å hole injection layer (hole injection layer material: Compound 70), a 300 Å hole transport layer (hole transport layer material: NPB), and 450 Å thickness BD-052X (on the ITO layer (anode) formed on the glass substrate Idemitsu Co., Ltd., 7% doped light emitting layer (where BD-052X is a blue fluorescent dopant and 9,10-di (naphthalen-2-yl) anthracene (ADN) was used as a light emitting host material), 250 kHz thick Electron transport layer (electron transport layer material: tris (8-quinolinolato) aluminum (Alq3)), 10 Å thick electron injection layer (electron injection layer material: LiF) and 1500 Å thick aluminum cathode were sequentially deposited An organic electroluminescent device was manufactured.

실험예1에 의해 제작된 유기전계발광소자의 구동전압, 전류밀도, 발광효율, 색좌표는 각각 5.63V, 13.77mA/cm2, 6.54cd/A, (0.146, 0.147)로 측정되었다.The driving voltage, current density, luminous efficiency, and color coordinates of the organic light emitting display device manufactured by Experimental Example 1 were measured as 5.63 V, 13.77 mA / cm 2 , 6.54 cd / A, and (0.146, 0.147), respectively.

실험예 2(본 발명의 화합물 43을 정공주입층으로 사용한 유기전계발광소자의 물성 측정) Experimental Example 2 (Measurement of Physical Properties of Organic Electroluminescent Device Using Compound 43 of the Present Invention as Hole Injection Layer)

화합물 43을 정공주입층 물질로 사용하여 통상적인 방법에 따라 유기전계발광소자를 제작하였다.An organic light emitting diode was manufactured according to a conventional method using compound 43 as a hole injection layer material.

먼저, 유리 기판에 형성된 ITO층(양극) 위에 600 Å 두께의 정공주입층(정공주입층 물질 : 화합물 92), 300Å 두께의 정공수송층(정공수송층 물질 : NPB), 450 Å 두께의 BD-052X(Idemitsu사)가 7% 도핑된 발광층(이때, BD-052X는 청색 형광 도펀트이고, 발광 호스트 물질로는 9,10-디(나프탈렌-2-일)안트라센(ADN)을 사용하였다), 250 Å 두께의 전자수송층 (전자수송층 물질: 트리스(8-퀴놀리놀라토)알루미늄(Alq3)), 10 Å 두께의 전자주입층 (전자주입층 물질: LiF) 및 1500 Å 두께의 알루미늄 음극을 순차적으로 증착시켜 유기전계발광소자를 제작하였다.First, a 600 Å hole injection layer (hole injection layer material: Compound 92), a 300 Å hole transport layer (hole transport layer material: NPB), 450 Å thickness BD-052X (on the ITO layer (anode) formed on the glass substrate Idemitsu Co., Ltd., 7% doped light emitting layer (where BD-052X is a blue fluorescent dopant and 9,10-di (naphthalen-2-yl) anthracene (ADN) was used as a light emitting host material), 250 kHz thick Electron transport layer (electron transport layer material: tris (8-quinolinolato) aluminum (Alq3)), 10 Å thick electron injection layer (electron injection layer material: LiF) and 1500 Å thick aluminum cathode were sequentially deposited An organic electroluminescent device was manufactured.

실험예2에 의해 제작된 유기전계발광소자의 구동전압, 전류밀도, 발광효율, 색좌표는 각각 6.12V, 13.32mA/cm2, 6.28cd/A, (0.146, 0.148)로 측정되었다.The driving voltage, current density, luminous efficiency, and color coordinates of the organic light emitting display device manufactured by Experimental Example 2 were measured to be 6.12 V, 13.32 mA / cm 2 , 6.28 cd / A, and (0.146, 0.148), respectively.

2-TNATA를 정공주입층 물질로 사용한 유기전계발광소자와, 실험예 1 및 2의 유기전계발광소자의 물성을 표로 정리하면 다음의 표 1과 같다.The physical properties of the organic light emitting device using 2-TNATA as the hole injection layer material and the organic light emitting device of Experimental Examples 1 and 2 are summarized in Table 1 below.

정공주입층 물질Hole injection layer material Voltage
(V)
Voltage
(V)
CurrentDensity
(mA/cm2)
Currentdensity
(mA / cm 2 )
Efficiency
(㏅/A)
E fficiency
(㏅ / A)
CIE
(x, y)
CIE
(x, y)
대조구 1Control 1 2-TNATA2-TNATA 6.956.95 14.3114.31 5.215.21 (0.145, 0.143)(0.145, 0.143) 실험예 1Experimental Example 1 화합물 42Compound 42 5.635.63 13.7713.77 6.546.54 (0.146,
0.147)
(0.146,
0.147)
실험예 2Experimental Example 2 화합물 43Compound 43 6.126.12 13.3213.32 6.286.28 (0.146,
0.148)
(0.146,
0.148)

표 1을 통해 알 수 있는 바와 같이, 실험예 1 및 2의 유기전계발광소자는 2-TNATA를 정공주입층 물질로 사용한 유기전계발광소자와 비교할 때 실질적으로 동일한 색좌표를 나타내면서 구동전압과 전류밀도, 발광효율이 임계적 의의를 가지고 향상된 것을 알 수 있다.As can be seen from Table 1, the organic light emitting diodes of Experimental Examples 1 and 2 exhibit substantially the same color coordinates as the organic electroluminescent device using 2-TNATA as the hole injection layer material, and have a driving voltage, a current density, It can be seen that the luminous efficiency is improved with a critical significance.

또한, 본 발명의 화합물 12 및 15와 비교를 위해 정공수송층으로 NPB를 사용한 유기전계발광소자의 물성을 측정하였다.In addition, the physical properties of the organic electroluminescent device using NPB as the hole transport layer was measured for comparison with the compounds 12 and 15 of the present invention.

NPB(N,N'-Di-1-naphthyl-N,N'-diphenylbenzidine)를 정공수송층 물질로 사용하여 통상적인 방법에 따라 유기전계발광소자를 제작하였다. An organic light emitting diode was manufactured according to a conventional method using NPB (N, N'-Di-1-naphthyl-N, N'-diphenylbenzidine) as a hole transport material.

먼저, 유리 기판에 형성된 ITO층(양극) 위에 600 Å 두께의 정공주입층(정공주입층 물질 : 2-TNATA), 300 Å 두께의 정공수송층(정공수송층 물질 : NPB), 450 Å 두께의 BD-052X(Idemitsu사)가 7% 도핑된 발광층(이때, BD-052X는 청색 형광 도펀트이고, 발광 호스트 물질로는 9,10-디(나프탈렌-2-일)안트라센(ADN)을 사용하였다), 250 Å 두께의 전자수송층 (전자수송층 물질: 트리스(8-퀴놀리놀라토)알루미늄(Alq3)), 10 Å 두께의 전자주입층 (전자주입층 물질: LiF) 및 1500 Å 두께의 알루미늄 음극을 순차적으로 증착시켜 유기전계발광소자를 제작하였다.First, a 600 Å hole injection layer (hole injection layer material: 2-TNATA), a 300 Å hole transport layer (hole transport layer material: NPB), and 450 Å thickness BD- on the ITO layer (anode) formed on the glass substrate. Light-emitting layer doped with 052X (Idemitsu Co., Ltd.) 7% (where BD-052X is a blue fluorescent dopant and 9,10-di (naphthalen-2-yl) anthracene (ADN) was used as a light emitting host material), 250 전자 thick electron transport layer (electron transport layer material: tris (8-quinolinolato) aluminum (Alq 3 )), 10 Å thick electron injection layer (electron injection layer material: LiF) and 1500 Å thick aluminum cathode Evaporation was carried out to produce an organic light emitting display device.

이렇게 제작된 유기전계발광소자의 구동전압, 전류밀도, 효율, 색좌표는 각각 6.73V, 15.23mA/cm2, 5.32cd/A, (0.145, 0.147)로 측정되었다.The driving voltage, current density, efficiency, and color coordinates of the organic light emitting diode thus manufactured were measured as 6.73 V, 15.23 mA / cm 2 , 5.32 cd / A, and (0.145, 0.147), respectively.

실험예 3(본 발명의 화합물 12를 정공수송층으로 사용한 유기전계발광소자의 물성 측정) Experimental Example 3 (Measurement of Physical Properties of Organic Electroluminescent Device Using Compound 12 of the Present Invention as Hole Transport Layer)

화합물 12를 정공수송층 물질로 사용하여 통상적인 방법에 따라 유기전계발광소자를 제작하였다.Using organic compound 12 as a hole transport material, an organic light emitting display device was manufactured according to a conventional method.

먼저, 유리 기판에 형성된 ITO층(양극) 위에 600 Å 두께의 정공주입층(정공주입층 물질 : 2-TNATA), 300Å 두께의 정공수송층(정공수송층 물질 : 화합물 2), 450 Å 두께의 BD-052X(Idemitsu사)가 7% 도핑된 발광층(이때, BD-052X는 청색 형광 도펀트이고, 발광 호스트 물질로는 9,10-디(나프탈렌-2-일)안트라센(ADN)을 사용하였다), 250 Å 두께의 전자수송층 (전자수송층 물질: 트리스(8-퀴놀리놀라토)알루미늄(Alq3)), 10 Å두께의 전자주입층 (전자주입층 물질: LiF) 및 1500 Å 두께의 알루미늄 음극을 순차적으로 증착시켜 유기전계발광소자를 제작하였다.First, a 600 Å hole injection layer (hole injection layer material: 2-TNATA), a 300 Å hole transport layer (hole transport layer material: compound 2), and 450 Å thickness BD- are placed on the ITO layer (anode) formed on the glass substrate. Light-emitting layer doped with 052X (Idemitsu Co., Ltd.) 7% (where BD-052X is a blue fluorescent dopant and 9,10-di (naphthalen-2-yl) anthracene (ADN) was used as a light emitting host material), 250 Å thickness electron transport layer (electron transport layer material: tris (8-quinolinolato) aluminum (Alq3)), 10 층 thickness electron injection layer (electron injection layer material: LiF) and 1500 Å thick aluminum cathode The deposition produced an organic light emitting display device.

실험예3에 의해 제작된 유기전계발광소자의 구동전압, 전류밀도, 발광효율, 색좌표는 각각 5.23V, 14.76mA/cm2, 6.62cd/A, (0.144, 0.150)로 측정되었다.The driving voltage, current density, luminous efficiency, and color coordinates of the organic light emitting display device manufactured by Experimental Example 3 were measured as 5.23 V, 14.76 mA / cm 2 , 6.62 cd / A, and (0.144, 0.150), respectively.

실험예 4(본 발명의 화합물 15를 정공수송층으로 사용한 유기전계발광소자의 물성 측정) Experimental Example 4 (Measurement of Physical Properties of Organic Electroluminescent Device Using Compound 15 of the Present Invention as Hole Transport Layer)

화합물 15를 정공수송층 물질로 사용하여 통상적인 방법에 따라 유기전계발광소자를 제작하였다.Using the compound 15 as a hole transport material, an organic light emitting display device was manufactured according to a conventional method.

먼저, 유리 기판에 형성된 ITO층(양극) 위에 600 Å 두께의 정공주입층(정공주입층 물질 : 2-TNATA), 300Å 두께의 정공수송층(정공수송층 물질 : 화합물 49), 450 Å 두께의 BD-052X(Idemitsu사)가 7% 도핑된 발광층(이때, BD-052X는 청색 형광 도펀트이고, 발광 호스트 물질로는 9,10-디(나프탈렌-2-일)안트라센(ADN)을 사용하였다), 250 Å 두께의 전자수송층 (전자수송층 물질: 트리스(8-퀴놀리놀라토)알루미늄(Alq3)), 10 Å두께의 전자주입층 (전자주입층 물질: LiF) 및 1500 Å 두께의 알루미늄 음극을 순차적으로 증착시켜 유기전계발광소자를 제작하였다.First, a 600 Å hole injection layer (hole injection layer material: 2-TNATA), a 300 Å hole hole transport layer (hole transport layer material: Compound 49), and a 450 Å BD on the ITO layer (anode) formed on the glass substrate. Light-emitting layer doped with 052X (Idemitsu Co., Ltd.) 7% (where BD-052X is a blue fluorescent dopant and 9,10-di (naphthalen-2-yl) anthracene (ADN) was used as a light emitting host material), 250 Å thickness electron transport layer (electron transport layer material: tris (8-quinolinolato) aluminum (Alq3)), 10 층 thickness electron injection layer (electron injection layer material: LiF) and 1500 Å thick aluminum cathode The deposition produced an organic light emitting display device.

실험예4에 의해 제작된 유기전계발광소자의 구동전압, 전류밀도, 발광효율, 색좌표는 각각 5.55V, 14.21mA/cm2, 6.52cd/A, (0.144, 0.145)로 측정되었다.The driving voltage, current density, luminous efficiency, and color coordinates of the organic light emitting display device manufactured by Experimental Example 4 were measured to be 5.55V, 14.21mA / cm 2 , 6.52cd / A, (0.144, 0.145), respectively.

NPB를 정공수송층 물질로 사용한 유기전계발광소자와, 실험예 3 및 4의 유기전계발광소자의 물성을 표로 정리하면 다음의 표 2와 같다.The physical properties of the organic light emitting device using NPB as the hole transport layer material and the organic light emitting device of Experimental Examples 3 and 4 are summarized in Table 2 below.

정공수송층 물질Hole transport material Voltage
(V)
Voltage
(V)
CurrentDensity
(mA/cm2)
Currentdensity
(mA / cm 2 )
Efficiency
(㏅/A)
Efficiency
(㏅ / A)
CIE
(x, y)
CIE
(x, y)
대조구 2Control 2 2-TNATA2-TNATA 6.736.73 15.2315.23 5.325.32 (0.145,
0.147)
(0.145,
0.147)
실험예 3Experimental Example 3 화합물 12Compound 12 5.235.23 14.7614.76 6.626.62 (0.144,
0.150)
(0.144,
0.150)
실험예 4Experimental Example 4 화합물 15Compound 15 5.555.55 14.2114.21 6.526.52 (0.144,
0.145)
(0.144,
0.145)

표 2를 통해 알 수 있는 바와 같이, 실험예 3 및 4의 유기전계발광소자는 2-TNATA를 정공수송층 물질로 사용한 유기전계발광소자와 비교할 때 실질적으로 동일한 색좌표를 나타내면서 구동전압과 전류밀도, 발광효율이 임계적 의의를 가지고 향상된 것을 알 수 있다.As can be seen from Table 2, the organic electroluminescent devices of Experimental Examples 3 and 4 exhibit substantially the same color coordinates as the organic electroluminescent device using 2-TNATA as the hole transport layer material, and have the driving voltage, the current density, and the light emission. It can be seen that the efficiency has improved with critical significance.

위 결과들을 통해 본 발명의 화합물들은 정공주입층이나 정공수송층 물질로 유기전계발광소자에 사용될 경우 구동전압과 전류밀도, 발광효율 등 물리적 특성 개선을 바탕으로 고효율, 저전압, 고휘도, 장수명을 기대할 수 있다. 한편, 본 발명의 화합물들을 유기전계발광소자의 다른 유기물층에 사용되더라도 동일한 효과를 얻을 수 있는 것은 자명하다.Based on the above results, the compounds of the present invention can be expected to have high efficiency, low voltage, high brightness, and long life, based on improvements in physical characteristics such as driving voltage, current density, and luminous efficiency when used in an organic light emitting device as a hole injection layer or a hole transport layer material. . On the other hand, even if the compounds of the present invention are used in other organic material layer of the organic light emitting device it is obvious that the same effect can be obtained.

이상의 설명은 본 발명을 예시적으로 설명한 것에 불과한 것으로, 본 발명이 속하는 기술분야에서 통상의 지식을 가지는 자라면 본 발명의 본질적인 특성에서 벗어나지 않는 범위에서 다양한 변형이 가능할 것이다. 따라서, 본 명세서에 개시된 실시예들은 본 발명을 한정하기 위한 것이 아니라 설명하기 위한 것이고, 이러한 실시예에 의하여 본 발명의 사상과 범위가 한정되는 것은 아니다. 본 발명의 보호범위는 아래의 청구범위에 의하여 해석되어야 하며, 그와 동등한 범위 내에 있는 모든 기술은 본 발명의 권리범위에 포함되는 것으로 해석되어야 할 것이다.While the present invention has been described with reference to exemplary embodiments, it is to be understood that the invention is not limited to the disclosed exemplary embodiments. Accordingly, the embodiments disclosed herein are intended to be illustrative rather than limiting, and the spirit and scope of the present invention are not limited by these embodiments. The protection scope of the present invention should be interpreted by the following claims, and all the technologies within the equivalent scope should be interpreted as being included in the scope of the present invention.

도 1 내지 도 5는 본 발명의 화합물을 적용할 수 있는 유기전자소자의 예를 도시한 것이다.1 to 5 show examples of organic electronic devices to which the compounds of the present invention can be applied.

Claims (10)

아래 화학식으로 표시되는 화합물:Compound represented by the formula
Figure 112011034539527-pat00026
Figure 112011034539527-pat00026
위 화학식에 있어서, In the above formula, (1) A는 독립적으로 단일결합 또는 C6-10의 아릴렌기이며,(1) A is independently a single bond or an arylene group of C 6-10 , (2) R1, R2, R3는 각각 서로 독립적으로 수소원자 또는 C1-6의 알킬기이며,(2) R 1 , R 2 and R 3 are each independently a hydrogen atom or an alkyl group of C 1-6 , (3) Ar1, Ar2, Ar3는 서로 동일 또는 상이하며, 각각 독립적으로 C6-13의 아릴기, 또는 N을 포함하는 C6-18의 아릴기이며, 여기서 Ar1 및 Ar2는 이들이 결합한 N과 함께 고리를 형성할 수 있으며, (3) Ar 1 , Ar 2 , Ar 3 are the same as or different from each other, and each independently an aryl group of C 6-13 , or a C 6-18 aryl group including N, wherein Ar 1 and Ar 2 are Together with the N to which they are bound to form a ring, (4) Ar4는 독립적으로 수소원자, C6-C18 아릴기, -N(Ar5)2 또는 -N(Ar5)(Ar6)로 표현되는 아미노기로 구성된 군으로부터 선택된 하나이며, 여기서 Ar5 및 Ar6은 각각 독립적으로 C6-18의 아릴기이며, (4) Ar 4 is independently selected from the group consisting of a hydrogen atom, a C 6 -C 18 aryl group, an amino group represented by -N (Ar 5 ) 2 or -N (Ar 5 ) (Ar 6 ), wherein Ar 5 and Ar 6 are each independently an aryl group of C 6-18 , (5) n은 0 내지 5의 정수이다.(5) n is an integer of 0-5.
삭제delete 제1항에 있어서,The method of claim 1, 상기 화합물은,The compound is,
Figure 112009018902968-pat00027
,
Figure 112009018902968-pat00027
,
Figure 112009018902968-pat00028
,
Figure 112009018902968-pat00028
,
Figure 112009018902968-pat00029
Figure 112009018902968-pat00029
로 구성된 군으로부터 선택된 하나인 것을 특징으로 하는 화합물.Compounds, characterized in that one selected from the group consisting of.
제1항 또는 제3항에 있어서, The method according to claim 1 or 3, 상기 화합물은 용액 공정(soluble process)에 사용되는 것을 특징으로 하는 화합물.Said compound being used in a soluble process. 제1항 또는 제3항 중 하나의 화합물을 포함하는 1층 이상의 유기물층을 포함하는 유기전자소자.An organic electronic device comprising at least one organic material layer comprising a compound of claim 1. 제5항에 있어서, The method of claim 5, 상기 유기전자소자는 제1 전극, 상기 1층 이상의 유기물층 및 제2 전극을 순차적으로 적층된 형태로 포함하는 유기전계발광소자인 것을 특징으로 하는 유기전자소자.The organic electronic device is an organic electroluminescent device comprising a first electrode, the at least one organic material layer and the second electrode in a stacked form sequentially. 제6항에 있어서,The method of claim 6, 상기 유기물층은 정공주입층, 정공수송층, 발광층 및 전자주입층을 포함하며, 상기 화합물은 상기 정공주입층 및 상기 정공수송층 중 하나 이상에 포함된 것을 특징으로 하는 유기전자소자.The organic material layer includes a hole injection layer, a hole transport layer, a light emitting layer and an electron injection layer, the compound is an organic electronic device, characterized in that included in at least one of the hole injection layer and the hole transport layer. 제7항에 있어서,The method of claim 7, wherein 상기 화합물은 상기 발광층에 적색, 녹색, 청색, 흰색을 포함하는 인광 호스트 물질로 사용된 것을 특징으로 하는 유기전자소자.The compound is an organic electronic device, characterized in that used as a phosphorescent host material containing red, green, blue, white in the light emitting layer. 제7항에 있어서, The method of claim 7, wherein 상기 화합물을 용액 공정(soluble process)에 의해 상기 발광층을 형성하는 것을 특징으로 하는 유기전자소자.The compound is an organic electronic device, characterized in that to form the light emitting layer by a solution process (soluble process). 제5항의 유기전자소자를 포함하는 디스플레이장치와;A display device comprising the organic electronic device of claim 5; 상기 디스플레이장치를 구동하는 제어부를 포함하는 단말.And a control unit for driving the display device.
KR1020090026838A 2009-03-30 2009-03-30 Chemiclal having an asymmetric structure which froms the ring by combining carbazole and fluorine and organic electroric element using the same, terminal thererof KR101072812B1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
KR1020090026838A KR101072812B1 (en) 2009-03-30 2009-03-30 Chemiclal having an asymmetric structure which froms the ring by combining carbazole and fluorine and organic electroric element using the same, terminal thererof
CN201080015465.4A CN102482279B (en) 2009-03-30 2010-03-29 Organic electronic device and compound thereof and terminating machine
PCT/KR2010/001905 WO2010114267A2 (en) 2009-03-30 2010-03-29 Organic electronic device, compounds for same, and terminal
EP10758992.1A EP2415773B1 (en) 2009-03-30 2010-03-29 Organic electronic device, compounds for same, and terminal
JP2012501944A JP5390693B2 (en) 2009-03-30 2010-03-29 Organic electronic device and its compound, terminal
US13/262,479 US9233923B2 (en) 2009-03-30 2010-03-29 Organic compounds for organic electronic devices and terminals
JP2013187250A JP5902655B2 (en) 2009-03-30 2013-09-10 Organic electronic device and its compound, terminal

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020090026838A KR101072812B1 (en) 2009-03-30 2009-03-30 Chemiclal having an asymmetric structure which froms the ring by combining carbazole and fluorine and organic electroric element using the same, terminal thererof

Publications (2)

Publication Number Publication Date
KR20100108701A KR20100108701A (en) 2010-10-08
KR101072812B1 true KR101072812B1 (en) 2011-10-14

Family

ID=43129932

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020090026838A KR101072812B1 (en) 2009-03-30 2009-03-30 Chemiclal having an asymmetric structure which froms the ring by combining carbazole and fluorine and organic electroric element using the same, terminal thererof

Country Status (1)

Country Link
KR (1) KR101072812B1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009023155A1 (en) 2009-05-29 2010-12-02 Merck Patent Gmbh Materials for organic electroluminescent devices
KR101305934B1 (en) * 2010-11-19 2013-09-12 한국과학기술연구원 Chemical and Organic Electronic Element using the same, Terminal thereof
KR101282176B1 (en) * 2011-03-21 2013-07-04 덕산하이메탈(주) Chemical and Organic Electronic Element using the same, Electronic Device thereof
KR101973030B1 (en) * 2012-06-20 2019-04-30 덕산네오룩스 주식회사 Compound for organic electronic element, organic electronic element using the same, and a electronic device thereof
KR101708090B1 (en) 2013-12-11 2017-02-17 주식회사 두산 Organic lightingemitting compound and organic electroluminescent device using the same

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008062636A1 (en) 2006-11-24 2008-05-29 Idemitsu Kosan Co., Ltd. Aromatic amine derivative and organic electroluminescent element using the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008062636A1 (en) 2006-11-24 2008-05-29 Idemitsu Kosan Co., Ltd. Aromatic amine derivative and organic electroluminescent element using the same

Also Published As

Publication number Publication date
KR20100108701A (en) 2010-10-08

Similar Documents

Publication Publication Date Title
KR101070223B1 (en) Chemical comprising arylamino and organic electronic element using the same, terminal thererof
KR101115036B1 (en) Compound Containing Thianthrene And Organic Electronic Element Using The Same, Terminal Thereof
KR101181266B1 (en) Bisdiarylamine Chemical Comprising Carbazole Derivatives and Organic Electronic Element using the same, Terminal thereof
KR101245243B1 (en) Spiro Carbazole Compound And Organic Electronic Element Using The Same, Terminal Thereof
KR20120034648A (en) Bis-carbazole derivative, material for organic electroluminescent element and organic electroluminescent element using same
KR101282178B1 (en) Aromatic amine compund having various permutator and organic electroric element using the same, terminal thererof
KR101219475B1 (en) Compound Containing Indoloacridine And Organic Electronic Element Using The Same, Terminal Thereof
KR20110066763A (en) Compound containing indoloacridine and organic electronic element using the same, terminal thereof
KR20110016288A (en) Compound containing 5-membered heterocycle and organic electronic element using the same, terminal thereof
KR20130059265A (en) Compound for organic electronic element, organic electronic element using the same, and a electronic device thereof
JP2015135836A (en) Organic electroluminescent element and material for organic electroluminescent element
KR20110117549A (en) Compound containing dibenzothiophene, arylamine derivatives and organic electronic element using the same, terminal thereof
KR20120107240A (en) Chemical and organic electronic element using the same, electronic device thereof
KR101094691B1 (en) Cyclic Aromatic Carbazole Compound AND Organic Electronic Element Using The Same, Terminal Thereof
KR101181267B1 (en) Chemical Comprising Naphthylcarbazole Derivatives and Organic Electronic Element using the same, Terminal thereof
KR20110092262A (en) Compound containing 5-membered heterocycle and organic electronic element using the same, terminal thereof
KR101072812B1 (en) Chemiclal having an asymmetric structure which froms the ring by combining carbazole and fluorine and organic electroric element using the same, terminal thererof
KR101219485B1 (en) Chemical comprising dibenzocarbazole and organic electroric element using the same, terminal thererof
KR101270505B1 (en) Amine Compound Having Three Carbazole And Organic Electronic Element Using The Same, Terminal Thereof
KR101144356B1 (en) Chemiclal based on indenoflurorene core and organic electroric element using the same, terminal thererof
KR20110087768A (en) Aromatic amine compund and organic electroric element using the same, terminal thererof
KR20110058250A (en) Compound containing 5-membered heterocycle and organic electronic element using the same, terminal thereof
KR20110057400A (en) Chemiclal based on indenoflurorene core and organic electroric element using the same, terminal thererof
KR101130102B1 (en) Compound comprising at least two double bonds based on indenoflurorene and organic electroric element using the same, terminal thererof
KR101763838B1 (en) Compound Containing Ring Linked Via Carbazole and Fluorene And Organic Electronic Element Using The Same, Terminal Thereof

Legal Events

Date Code Title Description
A201 Request for examination
N231 Notification of change of applicant
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20140218

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20150618

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20160922

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20170824

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20180518

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20190221

Year of fee payment: 9